<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id><journal-id journal-id-type="publisher-id">vaccines</journal-id><journal-title-group><journal-title>Vaccines</journal-title></journal-title-group><issn pub-type="epub">2076-393X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11680062</article-id><article-id pub-id-type="doi">10.3390/vaccines12121313</article-id><article-id pub-id-type="publisher-id">vaccines-12-01313</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Integrated Approaches for the Delivery of Maternal and Child Health Services with Childhood Immunization Programs in Low- and Middle-Income Countries: Systematic Review Update 2011&#x02013;2020</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3127-3602</contrib-id><name><surname>Shah</surname><given-names>Monica P.</given-names></name><xref rid="af1-vaccines-12-01313" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0931-5474</contrib-id><name><surname>Morgan</surname><given-names>Christopher J.</given-names></name><xref rid="af2-vaccines-12-01313" ref-type="aff">2</xref><xref rid="af3-vaccines-12-01313" ref-type="aff">3</xref><xref rid="af4-vaccines-12-01313" ref-type="aff">4</xref><xref rid="c1-vaccines-12-01313" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Beeson</surname><given-names>James G.</given-names></name><xref rid="af4-vaccines-12-01313" ref-type="aff">4</xref><xref rid="af5-vaccines-12-01313" ref-type="aff">5</xref><xref rid="af6-vaccines-12-01313" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0003-7052-5638</contrib-id><name><surname>Peach</surname><given-names>Elizabeth</given-names></name><xref rid="af4-vaccines-12-01313" ref-type="aff">4</xref><xref rid="af7-vaccines-12-01313" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>Jessica</given-names></name><xref rid="af4-vaccines-12-01313" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>McPake</surname><given-names>Barbara</given-names></name><xref rid="af3-vaccines-12-01313" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2264-3229</contrib-id><name><surname>Wallace</surname><given-names>Aaron S.</given-names></name><xref rid="af1-vaccines-12-01313" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Casuccio</surname><given-names>Alessandra</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vaccines-12-01313"><label>1</label>Global Immunization Division, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA; <email>mshah2@cdc.gov</email> (M.P.S.); <email>ccu7@cdc.gov</email> (A.S.W.)</aff><aff id="af2-vaccines-12-01313"><label>2</label>Jhpiego, a Johns Hopkins University Affiliate, Baltimore, MD 21231, USA</aff><aff id="af3-vaccines-12-01313"><label>3</label>Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC 3053, Australia; <email>barbara.mcpake@unimelb.edu.au</email></aff><aff id="af4-vaccines-12-01313"><label>4</label>Burnet Institute, Melbourne, VIC 3004, Australia; <email>james.beeson@burnet.edu.au</email> (J.G.B.); <email>e.peach@unsw.edu.au</email> (E.P.); </aff><aff id="af5-vaccines-12-01313"><label>5</label>Department of Infectious Diseases, University of Melbourne, Melbourne, VIC 3053, Australia</aff><aff id="af6-vaccines-12-01313"><label>6</label>School of Translational Medicine, Monash University, Melbourne, VIC 3800, Australia</aff><aff id="af7-vaccines-12-01313"><label>7</label>Rural Clinical Campuses, University of New South Wales Medicine and Health, Sydney, NSW 2052, Australia</aff><author-notes><corresp id="c1-vaccines-12-01313"><label>*</label>Correspondence: <email>christopher.morgan@jhpiego.org</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>12</volume><issue>12</issue><elocation-id>1313</elocation-id><history><date date-type="received"><day>25</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>18</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>20</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background</bold>: The integration of maternal and child health services (MCH) with routine immunization is an important global health strategy, particularly in low- and middle-income countries (LMICs). However, evidence is lacking regarding the best practices for service integration and the effect of integration on immunization and linked health service outcomes. <bold>Methods</bold>: We searched publication databases and gray literature for articles published between 2011 and 2020 that include approaches to integrating MCH services with immunizations during the first two years of life in LMICs. Abstracts and full-text articles were screened for eligibility. For the included articles, data extraction and analysis examined the descriptive characteristics of studies, outcomes, and implementation considerations. <bold>Results</bold>: Among the 16,578 articles screened, 44 met the criteria for inclusion, representing 34 studies, of which 29 were from Africa. The commonly linked MCH services were family planning (24%), human immunodeficiency virus (HIV) diagnosis or care (21%), and malaria prevention or control (21%). Multiple integration strategies were typically used; the co-location of linked services (65%), the provision of extra services by immunization staff (41%), and/or the provision of extra information by immunization staff (41%) were the most common. In general, integration improved MCH service outcomes (76%) and was either beneficial (55%) or neutral for immunization (35%), with some examples in family planning, malaria, and HIV where integrated services were not beneficial. Important implementation considerations included the careful matching of target populations in service re-design, ensuring support from policy, logistics, and information systems, the provision of adequate training and support of staff to avoid overload, clear client communication regarding service integration, and the need to address community concerns. <bold>Conclusions</bold>: Integrating MCH services with routine immunization can expand linked services and improve immunization coverage. This study has identified key implementation considerations relevant to both childhood and adult vaccination programs. More research is needed regarding costs and client preferences.</p></abstract><kwd-group><kwd>integration</kwd><kwd>vaccination</kwd><kwd>immunization</kwd><kwd>service delivery</kwd><kwd>systematic review</kwd><kwd>maternal and child health</kwd><kwd>infant</kwd><kwd>HIV</kwd><kwd>malaria</kwd><kwd>family planning</kwd></kwd-group><funding-group><award-group><funding-source>National Health and Medical Research Council of Australia Postgraduate Scholarship</funding-source><award-id>1075065</award-id></award-group><award-group><funding-source>NHMRC Investigator Grant</funding-source></award-group><award-group><funding-source>NHMRC Independent Research Institutes Infrastructure Support Scheme</funding-source><funding-source>Victorian Government Operational Infrastructure Support grant</funding-source></award-group><funding-statement>Partial support was received by CJM from a National Health and Medical Research Council of Australia Postgraduate Scholarship [1075065]. J.G.B. is supported by a NHMRC Investigator Grant, and Burnet Institute is supported by the NHMRC Independent Research Institutes Infrastructure Support Scheme and Victorian Government Operational Infrastructure Support grant.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vaccines-12-01313"><title>1. Introduction</title><p>The integration of other health and development interventions with immunization services has long been viewed as a cornerstone of global immunization strategies. The latest global framework, known as Immunization Agenda 2030 (IA2030), states the strategic priority of ensuring that all people benefit from recommended immunizations, integrated with essential health services, across the life course [<xref rid="B1-vaccines-12-01313" ref-type="bibr">1</xref>]. Integrating other health interventions with immunization services can contribute to the goal of universal health coverage, where all people have access to the full range of quality health services they need, when and where they need them [<xref rid="B2-vaccines-12-01313" ref-type="bibr">2</xref>].</p><p>Several rationales exist for integrating other health interventions with immunization services. Providing a package of care in a single visit to eligible individuals and accompanying family members can address individual health needs more comprehensively than vertical or single-disease-focused practices, while also reducing the individual&#x02019;s time and financial costs of seeking care. Childhood immunization services have among the highest and most equitable coverage of any childhood health service [<xref rid="B3-vaccines-12-01313" ref-type="bibr">3</xref>]. Therefore, immunization visits may provide an important platform for increasing the coverage of other health interventions, particularly in low- and middle-income countries (LMICs) where the coverage of other health interventions may be substantially lower. Integration has the potential to also increase health system efficiency, which can facilitate expanded program reach. Increased efficiency and reach can reduce mortality and morbidity from both vaccine-preventable and non-vaccine-preventable diseases.</p><p>However, integrating services is not without concern, as a lack of sufficient investment could lead to overburdened health workers and a decreased quality of service, with potential impacts on service coverage and acceptability [<xref rid="B4-vaccines-12-01313" ref-type="bibr">4</xref>]. Additional concerns exist regarding the feasibility of service integration due to differing service delivery requirements for considerations such as privacy, delivery time, and the target age range [<xref rid="B5-vaccines-12-01313" ref-type="bibr">5</xref>,<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>]. </p><p>To inform global recommendations, 2 previous systematic reviews, published in 2009 and 2012, comprehensively examined 59 studies integrating maternal and child health (MCH) interventions with immunization services to synthesize the lessons learned and best practices [<xref rid="B4-vaccines-12-01313" ref-type="bibr">4</xref>,<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>]. The reported outcomes in the studies reviewed indicated the need for increased coverage for the linked services, although not necessarily to the same levels as seen for immunization services. However, most studies did not report outcomes for immunization services. The reviews noted continuing evidence gaps regarding the cost efficiency of integrating services and the impact of integration on immunization outcomes. Despite these evidence gaps, these reviews provided sufficient evidence to support the development of the 2018 World Health Organization (WHO) technical guidance on the integration of immunization services, entitled &#x0201c;Working Together: an integration resource guide for immunization services throughout the life course&#x0201d; [<xref rid="B7-vaccines-12-01313" ref-type="bibr">7</xref>]. This WHO guidance, aimed at national immunization programs within Ministries of Health, provides an overview of integration approaches and opportunities, as well as considerations of how to best integrate other health services with immunizations. </p><p>Since 2012, when the last systematic review on this topic was published [<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>], the interest in integrating services has continued to increase, due in large part to a focus on achieving universal healthcare. The 2023 Lusaka Agenda outlines a framework for how global health initiatives (GHIs), which generally focus on supporting a single health program such as immunization, can support a more coordinated approach to strengthening primary healthcare in the integrated delivery of services at a high and equitable level of coverage [<xref rid="B8-vaccines-12-01313" ref-type="bibr">8</xref>]. Additionally, since 2012, new vaccines have been introduced, and many LMICs have additional doses in the second year of life, providing new opportunities to examine how to integrate health services for these age groups [<xref rid="B9-vaccines-12-01313" ref-type="bibr">9</xref>]. Meanwhile, efforts to &#x02018;catch children up&#x02019; on earlier missed vaccines&#x02014;such as the Big Catch-Up during the COVID-19 pandemic&#x02014;have focused on how to opportunistically integrate immunization into other health services [<xref rid="B10-vaccines-12-01313" ref-type="bibr">10</xref>]. This new context places a greater emphasis on understanding how best to integrate immunization services, tracking the latest evidence that has emerged across studies. </p><p>To inform global, regional, and country-level strategies with the new evidence on the integrated delivery of MCH interventions with immunization services, we undertook an update from the last systematic review on this topic, which reflected studied published up through 2010 [<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>]. In this review update, we synthesized published and unpublished literature from 2011 to 2020 on integrated approaches for the delivery of MCH services along with childhood immunization programs in LMICs. The objectives of this review were to describe the types of intervention, immunization service delivery platform (fixed, outreach, campaign, mixed), and service change (such as the co-location of services, the provision of extra information or counseling provided, the provision of extra services) used to integrate other services with immunization services provided in the first two years of life. We qualitatively summarized the effect of integration on linked MCH service and immunization outcomes (if measured and reported) and described implementation considerations for integrated service delivery changes. </p></sec><sec id="sec2-vaccines-12-01313"><title>2. Materials and Methods</title><p>The methodology used to conduct this systematic review update draws from the standardized guidelines developed by the Cochrane Collaboration&#x02019;s Effective Practice and Organization of Care group [<xref rid="B11-vaccines-12-01313" ref-type="bibr">11</xref>]. Detailed information about the methods is described in a protocol registered with the International Prospective Registry of Systematic Reviews [<xref rid="B12-vaccines-12-01313" ref-type="bibr">12</xref>]; a brief summary is provided here. </p><sec id="sec2dot1-vaccines-12-01313"><title>2.1. Search Methods</title><p><bold>Electronic searches:</bold> The following databases were searched on 13 May 2016; 15 May 2020; and 10 March 2023 for articles published between January 2011 and June 2020 (covering the next decade since the previous review [<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>]) in the English language using a search strategy combining terms for service types (e.g., antenatal, malaria, vitamin A, etc.), similar to a previous review on this topic [<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>], with additional search terms using integration terminology (full list of terms provided in PROSPERO protocol CRD42016045876 [<xref rid="B12-vaccines-12-01313" ref-type="bibr">12</xref>]: MEDLINE (via Ovid), EMBASE (via Ovid), CABI Global Health (via EBSCOhost), CINAHL (via EBSCOhost), Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews. <bold>Searching other resources:</bold> Additional publications were identified from the gray literature search of documents from the following agencies: World Health Organization (WHO), UNICEF, BASICS, Family planning&#x02014;EPI integration working group, Knowledge4Health, POPLINE, John Snow Incorporated, Family Health International, USAID-supported programs, DfID, and the Nigerian Urban Reproductive Health Initiative. </p></sec><sec id="sec2dot2-vaccines-12-01313"><title>2.2. Criteria for Inclusion and Exclusion</title><p>All study designs reporting empirical data were included, while articles from mathematical modeling studies were excluded. Additionally, expert opinions (e.g., perspective articles) and studies that did not focus on the operational impact of integrated service delivery were excluded. Other systematic reviews were excluded, although their reference lists were reviewed to identify any additional eligible studies. We included studies that integrated health services with childhood immunization programs for children aged two years or younger. The review was limited to data from LMICs, as defined by the World Bank for 2016 [<xref rid="B13-vaccines-12-01313" ref-type="bibr">13</xref>]. Studies were eligible for inclusion if they included one or more linked service and one or more immunization service that had been integrated during pregnancy, postnatally, or in childhood (including the first two years of life) as a function of health service innovation. Studies reporting on missed opportunities for vaccination, where the contact point for integration was health services other than immunization delivery, were not included in this review.</p><p>We included studies that involved comparisons with a non-integration population group or pre&#x02013;post integration comparisons. We excluded studies that had no comparator population group or timeframe. For inclusion in outcome synthesis, studies had to report one or more of the following outcomes for at least one immunization or linked health service: vaccination coverage, vaccination drop-out rates (e.g., first dose of diphtheria-tetanus-pertussis-containing vaccine [DTP1] to DTP3, first dose of pentavalent vaccine [DTP + hepatitis B + Haemophilus influenzae type B; penta1] to penta3), the coverage of a linked MCH service, the number or uptake of services provided (e.g., doses administered, number of tests administered, etc.), the quality of care, the equity of access or coverage, or costs.</p></sec><sec id="sec2dot3-vaccines-12-01313"><title>2.3. Selection of Studies</title><p>Two review authors screened all titles and abstracts for inclusion and assessed full-text articles for eligibility. For studies included at the full-text stage, two review authors extracted data from each article in a pre-tested standardized excel template. Any discrepancies were resolved through discussion or by a third reviewer. Covidence systematic review software (Veritas Health Innovation; Melbourne, Australia) was used to manage the independent assessment of articles across authors at the title/abstract and full-text stages. </p><p>During title and abstract screening, multiple publications from the same study were included as individual articles. At the full-text stage, multiple articles from the same study were collated as a single study. Additionally, studies that did not meet inclusion criteria at the full-text stage were listed in a table with their reasons for exclusion. The study selection process was summarized using a Preferred Reporting Items of Systematic reviews and Meta-Analyses (PRISMA) diagram [<xref rid="B14-vaccines-12-01313" ref-type="bibr">14</xref>]. </p></sec><sec id="sec2dot4-vaccines-12-01313"><title>2.4. Data Extraction</title><p>The data extraction template included the following variables: the descriptive characteristics of the study (e.g., geographic location(s), the year of publication, the timing of data collection, etc.); the study design, including comparison groups; the immunization platform selected for integrated service delivery (e.g., either routine or campaign, and further described by fixed, outreach, mobile, or mixed delivery routes); a description of the integration strategy, including the immunization service (e.g., specific vaccines) and additional health service being linked; outcome measures for both the immunization and linked service; and implementation determinants, considering the perspectives of providers of care and recipients of care, health systems, and the social and political context.</p><p>The quality of the evidence was assessed using frameworks derived from GRADE assessments [<xref rid="B15-vaccines-12-01313" ref-type="bibr">15</xref>] for quantitative data and from the Clinical Appraisal Skills Program (CASP) tools [<xref rid="B16-vaccines-12-01313" ref-type="bibr">16</xref>] for qualitative data. Since meta-analyses were not conducted and the risk of bias was not a consideration affecting inclusion, the results of the risk of bias assessment are not presented here. </p></sec><sec id="sec2dot5-vaccines-12-01313"><title>2.5. Data Synthesis</title><p>Narrative summaries were compiled for key results, following standard practices [<xref rid="B17-vaccines-12-01313" ref-type="bibr">17</xref>,<xref rid="B18-vaccines-12-01313" ref-type="bibr">18</xref>], based on the consensus among three authors (C.J.M., M.P.S., A.S.W.). As part of data synthesis, integration strategies were categorized as one or more of the following: a. extra services provided by immunization staff (i.e., testing, treatment, referrals, etc.); b. extra information and/or counseling provided by immunization staff (i.e., one-on-one consultation, providing informational materials, etc.); c. the co-location of services (e.g., same timing or same physical location of immunization delivery and linked health service); d. vaccination provided by non-immunization staff; and e. extra information and/or counseling provided by non-immunization staff (i.e., screening, health education, or immunization promotion, etc.). The results are summarized in a table that is arranged by EPI platform (campaign versus routine), linked health service(s), and study (designated by first author&#x02019;s last name and year of publication). </p><p>A single qualitative summary was used to summarize the direction of effect of the integration for the primary outcome(s) for immunization and for the linked MCH service separately. The terms used are defined as follows: &#x0201c;not measured&#x0201d;&#x02014;there was no outcome measured or no non-integration comparison group available; &#x0201c;negative&#x0201d;&#x02014;there was lower coverage or service provision in the integration compared to the non-integration group; &#x0201c;mixed negative&#x0201d;&#x02014;some outcomes were lower in the integration compared to the non-integration group, but others remained static; &#x0201c;static&#x0201d;&#x02014;no meaningful difference in coverage or service provision between integration and non-integration groups; &#x0201c;mixed positive&#x0201d;&#x02014;some outcomes were higher in the integration compared to the non-integration group, but others remained static; or &#x0201c;positive&#x0201d;&#x02014;higher coverage or service provision in the integration compared to the non-integration group. The results are summarized in a table that is arranged by EPI platform (campaign versus routine), linked MCH service(s), integration strategy, and study.</p><p>A narrative synthesis was undertaken to synthesize study findings related to the implementation considerations that affected service integration. Implementation considerations affecting service integration were collected into pre-defined categories, including policy and governance topics; the design of integrated service delivery; human resources for health; management, logistics, and costs; operational tools, reporting, and recording; and community and client topics [<xref rid="B19-vaccines-12-01313" ref-type="bibr">19</xref>]. </p><p>Data were managed, summarized, and synthesized in Microsoft Excel. </p></sec></sec><sec sec-type="results" id="sec3-vaccines-12-01313"><title>3. Results</title><sec id="sec3dot1-vaccines-12-01313"><title>3.1. Results of Search</title><p>A total of 21,894 records were identified via database searching and, after removing duplicates, 16,578 titles and abstracts were screened (<xref rid="vaccines-12-01313-f001" ref-type="fig">Figure 1</xref>). Among these, 471 full-text articles (from 467 studies) were reviewed and 44 articles (from 34 studies) met the eligibility criteria for inclusion; a full list of full-text articles (<italic toggle="yes">n</italic> = 427) that did not meet eligibility criteria and the reason for exclusion is provided as in the <xref rid="app1-vaccines-12-01313" ref-type="app">Supplementary Materials</xref> as <xref rid="app1-vaccines-12-01313" ref-type="app">Table S1</xref>, List of studies excluded on full-text review and reason for exclusion (<italic toggle="yes">n</italic> = 427). The most common reasons for full-text exclusion were wrong study design (34%), wrong publication type (27%), or articles not reporting on service delivery integration as the intervention (25%). </p><p>At the title and abstract screening stage, reviewers A and B had substantial agreement (Cohen&#x02019;s kappa: 0.71), while reviewers A and C had fair agreement (Cohen&#x02019;s kappa: 0.22). At the full-text stage, reviewers A and B and B and C had fair agreement (Cohen&#x02019;s kappa 0.31 and 0.33, respectively), while reviewers A and C had a level of agreement no better than what would be expected by chance (Cohen&#x02019;s kappa: 0). </p></sec><sec id="sec3dot2-vaccines-12-01313"><title>3.2. Description of Included Studies</title><p>Of the 34 studies included on integrated service delivery (<xref rid="vaccines-12-01313-t001" ref-type="table">Table 1</xref>, <xref rid="vaccines-12-01313-t002" ref-type="table">Table 2</xref>, <xref rid="vaccines-12-01313-t003" ref-type="table">Table 3</xref> and <xref rid="vaccines-12-01313-t004" ref-type="table">Table 4</xref>), 29 (85%) were conducted in Africa (Benin, Burkina Faso, Cameroon, Gambia, Ghana, Kenya, Liberia, Malawi, Mali, Madagascar, Nigeria, Rwanda, Sierra Leone, South Africa, South Sudan, Tanzania, and Zambia), 4 (12%) were conducted in Asia (Afghanistan, India, Lao PDR, and Pakistan), and 1 (3%) was conducted in the Americas (Mexico). A majority of included studies reported about the integration of services with routine immunizations (88%) delivered at either health facilities (<italic toggle="yes">n</italic> = 20), outreach sessions (<italic toggle="yes">n</italic> = 3), mobile sites (<italic toggle="yes">n</italic> = 2), or a combination of sites (<italic toggle="yes">n</italic> = 5), while the remaining (<italic toggle="yes">n</italic> = 4, 12%) studies reported about the integration health services within immunization campaigns (<xref rid="vaccines-12-01313-t001" ref-type="table">Table 1</xref>). To summarize further, <xref rid="vaccines-12-01313-t001" ref-type="table">Table 1</xref>, <xref rid="vaccines-12-01313-t002" ref-type="table">Table 2</xref>, <xref rid="vaccines-12-01313-t003" ref-type="table">Table 3</xref> and <xref rid="vaccines-12-01313-t004" ref-type="table">Table 4</xref> are grouped by immunization delivery platform and/or linked health service; <xref rid="vaccines-12-01313-t001" ref-type="table">Table 1</xref> describes studies that were integrated into campaigns and includes 4 studies, performed in Lao PDR, Madagascar, Nigeria, and Pakistan. <xref rid="vaccines-12-01313-t002" ref-type="table">Table 2</xref> describes studies integrating child health screening or family planning advice and services into routine immunizations and includes 10 studies performed in Benin, Burkina Faso, Ghana, India, Liberia, Malawi, Nigeria, Rwanda, South Africa, and Zambia. <xref rid="vaccines-12-01313-t003" ref-type="table">Table 3</xref> reports studies integrating HIV and malaria services into routine immunizations and includes 7 HIV studies from Cameroon, Kenya, Malawi, Nigeria, Tanzania, and Zambia, and 7 malaria studies from Gambia, Ghana, Mali, Malawi, Rwanda, and Tanzania. Finally, <xref rid="vaccines-12-01313-t004" ref-type="table">Table 4</xref> describes the integration of primary healthcare (PHC) services; nutrition, water, sanitation, and hygiene (WASH); or a combination of services into routine immunizations and includes 7 studies conducted in Afghanistan, Kenya, Mexico, Nigeria, Sierra Leone, and South Sudan.</p><p>Linked health services included child health, hearing, or vision screening (<xref rid="vaccines-12-01313-t002" ref-type="table">Table 2</xref>); family planning (<xref rid="vaccines-12-01313-t002" ref-type="table">Table 2</xref>); HIV prevention, diagnosis, and treatment (<xref rid="vaccines-12-01313-t003" ref-type="table">Table 3</xref>); malaria prevention, control, and treatment (<xref rid="vaccines-12-01313-t003" ref-type="table">Table 3</xref>); packages of MCH and/or other PHC services, including antenatal care (ANC), prenatal care (PNC), and the integrated management of childhood illnesses (IMCI) (<xref rid="vaccines-12-01313-t004" ref-type="table">Table 4</xref>); nutrition; WASH services (<xref rid="vaccines-12-01313-t004" ref-type="table">Table 4</xref>); or a combination of these (e.g., PHC and nutrition; family planning and nutrition; malaria, PHC, nutrition, and WASH; this is shown in <xref rid="vaccines-12-01313-t004" ref-type="table">Table 4</xref>). Of these, the most commonly reported linked health services were family planning (24%; of which, there were <italic toggle="yes">n</italic> = 7 in Africa and <italic toggle="yes">n</italic> = 1 in India), HIV (21%; of which, there was <italic toggle="yes">n</italic> = 7 in Africa [100%]), and malaria (21%; of which, <italic toggle="yes">n</italic> = 7 in Africa [100%]). Only four studies reported the integration of multiple health services with routine immunization service delivery (<xref rid="vaccines-12-01313-t004" ref-type="table">Table 4</xref>), and this was observed in Bawa, 2019 (malaria, PHC, nutrition, and WASH) [<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>]; Edmond, 2020 (PHC and nutrition) [<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>]; Habib, 2017 (PHC and nutrition) [<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>]; and Hodges, 2015 (family planning and nutrition) [<xref rid="B24-vaccines-12-01313" ref-type="bibr">24</xref>].</p><p>The risk of bias was assessed as described in the Materials and Methods Section; most studies were rated as having a high risk of bias due to the implementation science framework of many study designs. As a result, the risk of bias assessment result was not considered as a criterion for inclusion in the review.</p><table-wrap position="anchor" id="vaccines-12-01313-t001"><object-id pub-id-type="pii">vaccines-12-01313-t001_Table 1</object-id><label>Table 1</label><caption><p>Characteristics of included studies (<italic toggle="yes">n</italic> = 4) on integration into immunization campaigns by linked health service, systematic review update 2011&#x02013;2020.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin;background:#D0CECE" rowspan="1" colspan="1">Study <sup>a</sup></th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin;background:#D0CECE" rowspan="1" colspan="1">Country (Study Year(s))</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin;background:#D0CECE" rowspan="1" colspan="1">Immunization Delivery Platform</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin;background:#D0CECE" rowspan="1" colspan="1">Linked Maternal and Child Health Service(s)</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin;background:#D0CECE" rowspan="1" colspan="1">Integration Strategy</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin;background:#D0CECE" rowspan="1" colspan="1">Description of <break/>Integration Strategy </th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin;background:#D0CECE" rowspan="1" colspan="1">Study Design: <break/>Outcome Comparison</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin;background:#D0CECE" rowspan="1" colspan="1">Immunization <break/>Outcomes Measured (Primary Outcome in Bold)</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin;background:#D0CECE" rowspan="1" colspan="1">Linked Health <break/>Service Outcomes Measured (Primary Outcome in Bold)</th></tr></thead><tbody><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Goodson (2012) and Kulkarni (2010) [<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Madagascar [2007&#x02013;2008]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Campaign&#x02014;mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Integrated delivery of ITNs, deworming tablets, vit A and measles vaccine to &#x0003c;5-year-olds during a national health campaign.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Post only; two groups [integration = ITNs distributed in campaign package of services; comparison = ITNs were not included]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Measles vaccination coverage (higher in integration group compared to non-ITN control group, including in poorest households)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Proportion of households with at least one ITN (higher in integration compared to non-integration areas)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Habib (2017) [<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pakistan [2013&#x02013;2014]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Campaign&#x02014;mixed (fixed and mobile camps)</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nutrition, PHC </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">b. Extra information and/or counseling by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">MCH camps alongside polio campaign, offered counseling on hygiene and nutrition, routine immunizations, micronutrient supplements, and general MCH assessments.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; three groups: comparison = OPV with routine immunizations; integration 1 = OPV with routine immunizations and other interventions; integration 2 = OPV with routine immunizations, other interventions, and IPV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-OPV coverage (higher in integration groups versus comparison)</bold>
<break/>
<bold>-Other routine immunization coverage (higher in integration groups versus comparison)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Updates of PHC services noted but were not quantifiable due to lack of comparison data.</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Boselli (2011) [<xref rid="B27-vaccines-12-01313" ref-type="bibr">27</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Lao PDR [2007]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Campaign&#x02014;mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nutrition</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Integrated deworming tablets, vit A and polio vaccine to &#x0003c;5-year-olds. Deworming tablets with tetanus toxoid vaccine to women</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Only examined cost effectiveness of integrated vit A and deworming tablet delivery compared to non-integrated delivery</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Birukila (2017) [<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria [2013]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Campaign&#x02014;mixed (fixed and temporary sites)</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">PHC</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">During polio campaigns, health camps were organized for settlements with high vaccine refusal rates in which other health services were offered with OPV. </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Historical comparison 2013 with 2014; integration group = settlements with integrated health camps (polio and other primary healthcare services) in 2013. </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Number of children who received OPV (14,000 in 2013 round with integrated health camps and 7000 in 2014 round without integrated health camps)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> the last name of the first author and the publication year; studies are ordered by linked maternal and child health service, and then alphabetically by author. Notes: ITN = insecticide-treated bednet; IPV = inactivated polio vaccine; MCH = maternal and child health; OPV = oral polio vaccine; PHC = primary healthcare; vit A = vitamin A supplementation.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="vaccines-12-01313-t002"><object-id pub-id-type="pii">vaccines-12-01313-t002_Table 2</object-id><label>Table 2</label><caption><p>Characteristics of included studies (<italic toggle="yes">n</italic> = 10) on integration of child health or family planning into routine immunizations, systematic review update 2011&#x02013;2020.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Study <sup>a</sup></th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Country (Study Year(s))</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Immunization Delivery Platform</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Linked Maternal and Child Health Service(s)</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Integration Strategy</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Description of <break/>Integration Strategy </th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Study Design: <break/>Outcome Comparison</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Immunization <break/>Outcomes Measured (Primary Outcome in Bold)</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Linked Health <break/>Service Outcomes Measured (Primary Outcome in Bold)</th></tr></thead><tbody><tr><td colspan="9" align="left" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1">Integration into routine immunization&#x02014;child hearing screening</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Friderichs (2012) [<xref rid="B29-vaccines-12-01313" ref-type="bibr">29</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">South Africa [2008&#x02013;2010]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Child health (hearing screening)</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">EPI staff administered a hearing screening test; no non-integration comparison.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Not applicable/no relevant outcomes compared: feasibility study only.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Proportion of infants that underwent hearing screening. No comparator.</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Jac-Okereke (2020) [<xref rid="B30-vaccines-12-01313" ref-type="bibr">30</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria [ND]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Child health (vision screening)</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Infants attending immunization clinics randomly selected for vision screening.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Not applicable/no relevant outcomes compared: descriptive study only. </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td></tr><tr><td colspan="9" align="left" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1">Integration into routine immunization&#x02014;family planning (FP) advice and services</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Balasubramaniam (2018) [<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">India [2012]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;outreach</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">b. Extra information and/or counseling by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Providers applied a screening tool to assess for FP; both intervention and control areas updated in post-partum FP.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Mid-point/end-line; two groups [integration group = use of FP screening tool in intervention areas]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>DTP3 coverage (similar increases in intervention and control)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Percentage of women receiving FP services (no change in intervention, control decreased).</bold>
<break/>
<bold>FP methods (increased in intervention, but no change in control)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Cooper (2015) [<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Liberia [2012]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">b. Extra information and/or counseling by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pilot of FP counseling by immunization staff at routine immunization visits and same-day referral to a co-located FP service. </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; two groups [integration group = pilot facilities comparator non-pilot facilities and pre-intervention data]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>-Provision of DTP1 and DTP3 (increase from pre to post and higher in pilot vs non-pilot in one site, but no differences in other sites)</bold><break/>-DTP1&#x02014;3 drop-out rate (increased from pre to post and higher in pilot facilities compared to non-pilot at both sites).</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-New contraceptive users (increased from pre- to post-intervention in both sites)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Cooper (2020) [<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malawi [2016&#x02013;2017]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mixed (facility and outreach)</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff<break/>c. Co-location<break/>e. Extra information and/or counseling by non-immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Same-day family planning services offered by nurses and health surveillance assistants to mothers seeking routine immunization services; screening of vaccination status for infants of family planning clients.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; one group</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Number of DTP1 doses (no change)</bold>
<break/>
<bold>-Number of DTP3 doses (increase from pre to post)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Number of women accessing FP services (increase from pre to post)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Dulli (2016) [<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>] </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Rwanda [2010&#x02013;2011]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">b. Extra information and/or counseling by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunization staff provided information on FP and referral for counseling to co-located services. Compared to health facilities not using integrated approach.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; two groups [integration group = health facilities implementing integrated family planning and immunization services]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>-Monthly trends in measles vaccinations (similar in integration and non-integration health facilities)</bold><break/>-Monthly trends in DTP1, 2, and 3 collected but not reported</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Proportion of women using a modern contraceptive method (higher in integration health facilities compared to non-integration group)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Erhardt-Ohren (2020) [<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Benin [2016&#x02013;2017]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">b. Extra information and/or counseling by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunization staff provided information on FP and referral for FP counseling.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Not applicable/no relevant outcomes compared: qualitative process evaluation.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nelson (2019) [<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Liberia [2016&#x02013;2017]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">b. Extra information and/or counseling by immunization staff<break/>c. Co-location<break/>e. Immunization counselling by non-immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunization staff provided information on FP and referral for counseling to co-located services. Compared to matched facilities not using integration.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; two groups [integration group = health facilities implementing integrated family planning and immunization services]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-DTP1&#x02013;3 drop-out rates (similar in integration and non-integration health facilities)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-FP referral (increased over time, higher in integration than non-integration)</bold>
<break/>
<bold>-Contraceptive acceptance (higher in integration than non-integration facilities)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Vance (2014) [<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Ghana and Zambia [2009&#x02013;2010]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">b. Extra information and/or counseling by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunization staff provided information on FP and referral for services at nine-month visit at intervention health facilities. Outcomes compared to non-intervention (control) facilities.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; two groups [integration group = health facilities where vaccinators were trained to provide FP messages and referrals to women presenting for child immunization services]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Non-condom contraceptive use (no changes in intervention compared to control)</bold>
<break/>
<bold>-Women&#x02019;s knowledge of LAM (no differences)</bold>
<break/>
<bold>-Referrals for FP services (non-significant changes across groups)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Yugbare Belemsaga (2018) [<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Burkina Faso [2013&#x02013;2015]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff<break/>b. Extra information and/or counseling by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Provision of maternal-infant post-partum care checks and FP counseling at same time as immunization visits, by co-located staff.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; one group</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Monthly number of doses of DTP administered (no change over time)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Uptake of post-partum care at immunization visits (no pre&#x02013;post changes overall, some increase during the early post-natal period)</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> the last name of the first author and the publication year; studies are ordered by linked maternal and child health service, and then alphabetically by author. Notes: DTP = diphtheria, pertussis, and tetanus vaccine; EPI = expanded program on of immunizations; FP = family planning; LAM = lactational amenorrhea method.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="vaccines-12-01313-t003"><object-id pub-id-type="pii">vaccines-12-01313-t003_Table 3</object-id><label>Table 3</label><caption><p>Characteristics of included studies (<italic toggle="yes">n</italic> = 13) on integration of human immunodeficiency virus (HIV)prevention, testing, and treatment or malaria into routine immunizations, systematic review update 2011&#x02013;2020.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Study <sup>a</sup></th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Country (Study Year(s))</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Immunization Delivery Platform</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Linked Maternal and Child Health Service(s)</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Integration Strategy(ies)</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Description of <break/>Integration Strategy </th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Study Design: <break/>Outcome Comparison</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Immunization <break/>Outcomes Measured (Primary Outcome in Bold)</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Linked Health <break/>Service Outcomes Measured (Primary Outcome in Bold)</th></tr></thead><tbody><tr><td colspan="9" align="left" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1">Integration into routine immunization&#x02014;HIV services</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Dube 2012 [<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malawi [2008&#x02013;2010]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Testing, counseling, and treatment for EID of HIV offered at 6-week EPI visit.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Not applicable/no relevant outcomes compared: feasibility study to describe completion of EID process during routine EPI visits.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">-Measured, but no non-integration comparator <break/>-71.6% of HEIs had early diagnosis, 87.3% of mothers informed of infants&#x02019; results, ART started in 58% of infants with confirmed infection.</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Goodson (2013) and Wallace (2014) [<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Tanzania [2009&#x02013;2010]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff<break/>b. Extra information and/or counseling by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">EPI staff identified HEIs offered testing, counseling and care in selected sites. Compared to remaining sites in district (control).</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">For immunization outcome: pre/post; two groups [integration group]<break/>For linked service: not applicable/no relevant outcomes compared&#x02014;feasibility study only.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Monthly vaccine doses [OPV1, OPV3, Penta1, Penta3, Measles] (results differed by urban/rural and by antigen; overall either no change or a decrease in monthly doses)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>-Measured, but no non-integration comparator</bold><break/>-HIV service uptake increased in all sites</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">McCollum (2012) [<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malawi [2011]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">b. Extra information and/or counseling by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Testing and counseling for EID of HIV offered at EPI clinic. Compared to EID offered at pediatric clinic.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Post only; two groups [integration group = infants attending EPI clinic where EID service was co-located]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Proportion of infants receiving provider initiated HIV testing and counseling for EID (higher in EPI than pediatric clinic)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Odafe (2020) [<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria [2016&#x02013;2017]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Targeted HIV testing of infants in immunization clinics compared to in TB clinics, inpatient wards, outpatient clinics, and through a family registry system.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Post only; five platforms/groups [integration group = immunization clinics]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Proportion of all tests by platform (testing at immunization clinics low [0.9%] compared to others: pediatric outpatients [49.7%], family registry [38.0%], pediatric inpatient [10.5%], or tuberculosis [0.8%] clinics)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Ong&#x02019;ech (2012) [<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Kenya [2008&#x02013;2010]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Services for HEIs (infant feeding support, prophylactic medicines, and HIV diagnosis) offered at MCH clinics with EPI services co-located compared to specialized HIV clinic. </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Post only; two groups [integration group = infants seeking care at MCH clinic offering EPI and HEI services]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Measles vaccine coverage at 9 months (higher in integrated MCH clinic than specialized HIV clinic)</bold>
<break/>
<bold>-Completion of vaccinations by 12 months (higher in integrated MCH clinic than specialized HIV clinic)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Odds of attending scheduled post-natal visits (higher in integrated MCH clinic than specialized HIV clinic)</bold>
<break/>
<bold>-Proportion of infants attending follow-up (higher in integrated MCH clinic than specialized HIV clinic)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Tejiokem (2011) [<xref rid="B47-vaccines-12-01313" ref-type="bibr">47</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Cameroon [2007&#x02013;2009]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Testing, counseling, and treatment for EID of HIV offered at 6-, 10-, and 14-week EPI visit and linkage to HAART.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Not applicable/no relevant outcomes compared: feasibility study only.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">-Measured, but no non-integration comparator<break/>-Completeness of follow-up of HEIs (83.9% completed)</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang (2015) [<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Zambia [2012&#x02013;2014] </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff<break/>b. Extra information and/or counseling by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">EPI and co-located staff, with commodity support, offered HIV testing and counseling. </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; three groups [control, simple intervention = re-supply of HIV commodities, integration group = integration of HIV testing with routine immunization]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>-Monthly DTP1 doses (similar change in both intervention arms and matched control sites)</bold><break/>-Qualitative finding: HIV services did not deter families from immunization.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Monthly HIV tests administered (higher in integration compared to simple intervention and control)</bold>
</td></tr><tr><td colspan="9" align="left" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1">
Integration into routine immunization&#x02014;malaria prevention
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Bojang (2011) [<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Gambia [2006]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;outreach</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">IPTc during outreach by community-based VHWs) compared to outreach by reproductive and child health trekking teams (EPI staff).</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Post only; two groups [integration group = RCH teams (EPI staff) delivery]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>% children &#x02265; 12 months who were fully vaccinated (lower in RCH teams compared to non-integrated VHW delivery)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>-Coverage of three courses of IPTc (lower in RCH teams delivery compared to non-integrated VHW)</bold><break/>-Cost of delivery at least first dose of IPTc (more expensive to deliver by RCH teams compared to VHWs)</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Dicko (2011) [<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>] </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Mali [2006&#x02013;2007]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">IPTi services and counseling by staff at EPI clinics in intervention sites. Compared to sites not offering IPTi.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; two groups [integration group = randomized areas where IPTi was delivered with routine vaccinations]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Coverage of fully vaccinated children 9&#x02013;23 months [BCG, 3 doses of DTP, 3 doses of polio, measles, and yellow fever vaccines] (increase in coverage in intervention compared to control and baseline)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>-Coverage of IPTi (higher in intervention compared to control)</bold><break/>-Coverage of vitamin A (higher in intervention compared to control)<break/>-ITN use (similar in intervention compared to control) </td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Patouillard (2011) [<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Ghana [2006]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;outreach</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff<break/>b. Extra information and/or counseling by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">IPTc delivery by VHWs compared to facility-based staff (at outpatient departments or EPI outreach clinics).</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Post only; two groups [integration group = facility-based delivery]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>-Coverage of IPTc (similar in VHW delivery and facility-based delivery)</bold><break/>-Cost of delivering full course of IPTc (more expensive to deliver by EPI nurses compared to VHWs)</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Scates 2020 [<xref rid="B53-vaccines-12-01313" ref-type="bibr">53</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Ghana, Mali, Tanzania [2015&#x02013;2016]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mixed (facility in Ghana, Tanzania, and Mali; community and facility in Zanzibar)</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Continuous distribution of insecticide-treated bednets (ITNs) by immunization staff through ANC, EPI, schools, and mass distribution campaign. </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Not applicable/no relevant outcomes compared: descriptive study of costs associated with various ITN continuous distribution delivery platforms.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Schellenberg (2011) and Willey (2011) [<xref rid="B54-vaccines-12-01313" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01313" ref-type="bibr">55</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Tanzania [2005&#x02013;2007]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">IPTi services and counseling by staff at EPI clinics in intervention sites. Compared to no IPTi control sites.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post for infant survival and post only for other outcomes; two groups [integration group = randomized areas where IPTi was delivered with routine vaccinations compared to no IPTi control]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-DTP3 and measles vaccination coverage (similar in IPTi vs no IPTi groups)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>-Coverage of three doses of IPTi (higher in intervention compared to control)</bold><break/>-Infant mortality (decrease over time, but no difference between intervention and control groups)</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Theiss-Nyland (2016b) and (2017) [<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Kenya, Malawi, Mali, Rwanda [2014]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Continuous distribution of LLINs through ANC and EPI</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Not applicable/no relevant outcomes compared: feasibility study of continuous distribution.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> the last name of the first author and the publication year; studies are ordered by linked maternal and child health service, and then alphabetically by author. Notes: ANC = antenatal care; ART = antiretroviral therapy; BCG = bacille Calmette&#x02013;Guerin vaccine; DTP = diphtheria, pertussis, and tetanus vaccine; EID = early infant diagnosis; EPI = expanded program of immunizations; HEI = HIV-exposed infant; HIV = human immunodeficiency virus; IPTc/i = intermittent preventive treatment for malaria during infancy/in children; ITN = insecticide-treated bednet; LLIN = long-lasting insecticidal nets; MCH = maternal and child health; OPV = oral polio vaccine;Penta = pentavalent vaccine; VHW = village health worker.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="vaccines-12-01313-t004"><object-id pub-id-type="pii">vaccines-12-01313-t004_Table 4</object-id><label>Table 4</label><caption><p>Characteristics of included studies (<italic toggle="yes">n</italic> = 7) on the integration of primary healthcare services, nutrition, water, sanitation, and hygiene (WASH), or a combination of services with routine immunizations, systematic review update 2011&#x02013;2020.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Study <sup>a</sup></th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Country (Study Year(s))</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Immunization Delivery Platform</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Linked Maternal and Child Health Service(s)</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Integration Strategy</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Description of <break/>Integration Strategy </th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Study Design: <break/>Outcome Comparison</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Immunization <break/>Outcomes Measured (Primary Outcome in Bold)</th><th align="left" valign="top" style="border-bottom:solid thin;border-top:solid thin" rowspan="1" colspan="1">Linked Health <break/>Service Outcomes Measured (Primary Outcome in Bold)</th></tr></thead><tbody><tr><td colspan="9" align="left" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1">Integration into routine immunization&#x02014;maternal depression screening</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Bakare (2014) and (2017) [<xref rid="B58-vaccines-12-01313" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01313" ref-type="bibr">59</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria [2012]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">PHC&#x02014;maternal depression</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Depression screening service co-located with EPI clinic visits.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Not applicable/no relevant outcomes compared: feasibility study only.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td></tr><tr><td colspan="9" align="left" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1">Integration into routine immunization&#x02014;nutrition activities</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Monterrosa (2013) [<xref rid="B60-vaccines-12-01313" ref-type="bibr">60</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Mexico [2011]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nutrition</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">b. Extra information and/or counseling by immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">EPI nurses and radio communications delivered scripted nutrition counseling messages. Behavior change among women with children 6&#x02013;24 months compared between with and without messages.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; two groups [integration group = sites receiving nutrition communications from EPI nurses and via radio]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>-Frequency of breast feeding (higher in integration group compared to sites not receiving nutrition communications)</bold><break/>-Self-reported feeding (mixed results but some healthier consumption in integration group)</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Oladeji (2019) [<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">South Sudan [2017]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mixed (nutrition treatment centers and community outreach)</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nutrition</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location<break/>e. Extra information and/or counseling by non-immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunization services offered to children visiting nutrition treatment clinics and nutrition community outreach. Nutrition volunteers provide messages on immunization, screen vaccination status and track children. Compared to immunization atPHCs.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Post only; two groups [integration group = immunization delivery at nutrition treatment clinics and community outreach]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">-Proportion of children vaccinated in nutrition treatment clinics compared to standard PHC clinics [BCG, OPV 0&#x02013;3, Penta 1&#x02013;3, IPV, and measles] (data insufficient for comparison)<break/><bold>-Drop-out Penta1 to Penta3 (lower drop-out in nutrition treatment clinics compared to PHCs)</bold></td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Not measured</bold>
</td></tr><tr><td colspan="9" align="left" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1">Integration into routine immunization&#x02014;water, sanitation, and hygiene interventions (WASH)</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Briere (2012) and (Ryman) 2012 [<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Kenya [2009]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">WASH</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">a. Extra services by immunization staff<break/>b. Extra information and/or counseling by immunization staff<break/>c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">During routine immunization visits, health workers offered water treatment, soap and related education to caregivers children aged &#x0003c;1 yr old.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; two groups [integration group = district randomly selected to integrate WASH interventions at routine immunization visits]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Percent of children 2&#x02013;20 months who received all vaccine doses [penta, OPV, and measles] (higher in intervention compared to control)</bold>
<break/>
<bold>-Percent of children 2&#x02013;20 months who received all age-appropriate vaccines (higher in intervention compared to control)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Awareness of water treatment options (increase in both intervention and control from pre to post)</bold>
<break/>
<bold>-Uptake of water treatment (significant pre&#x02013;post increase in intervention, not control)</bold>
<break/>
<bold>-Percentage of households with soap (pre&#x02013;post increase in intervention, not control)</bold>
</td></tr><tr><td colspan="9" align="left" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1">Integration into routine immunization&#x02014;multiple primary healthcare and disease control interventions</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Bawa (2019) [<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria [2014&#x02013;2015]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mobile</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria,<break/>PHC,<break/>Nutrition,<break/>WASH</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Package of MCH services (antenatal care, malaria prevention, iron folate, deworming, child health, WASH, vitamin A, nutrition screening, and routine immunizations) delivered to women and children during mobile outreach visits.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pre/post; one group</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Coverage of measles vaccination (increased from pre to post)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Provision of multiple MCH interventions (increase from pre to post)</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Edmond (2020) [<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Afghanistan [2013]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mobile</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">PHC,<break/>Nutrition</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Integrated outreach services for ANC, PNC, and immunization by mobile health teams (MHTs).</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Post only; two groups [integration group = recent MHT integrated outreach delivery, comparator = areas without recent visits]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Measles first dose coverage (higher in areas with recent MHT integrated outreach compared to non-recent)</bold>
<break/>
<bold>-Penta 3 coverage (higher in areas with recent MHT integrated outreach, but not statistically significant)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Coverage of at least one ANC visit (higher in areas with recent MHT integrated outreach)</bold>
<break/>
<bold>-Coverage of at least one PNC visit (no difference)</bold>
<break/>
<bold>-Coverage of facility-based delivery (no difference)</bold>
<break/>
<bold>-Coverage of at least one IMCI visit (higher in areas with recent MHT integrated outreach)</bold>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hodges (2015) [<xref rid="B24-vaccines-12-01313" ref-type="bibr">24</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Sierra Leone [2012&#x02013;2013]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Family planning,<break/>Nutrition</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">c. Co-location<break/>e. Extra information and/or counseling by non-immunization staff</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Extra co-located staff provided vit A and either IYCF counseling or IYCF and FP services, alongside routine and catch-up vaccination, during visits from 6 months of age onwards. Extra staff also gave information on catch-up vaccination.</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Post only; three groups [integration group 1 = revised vaccination card with vit A + IYCF + FP counseling, integration group 2 revised vaccination card with vit A, control group = revised vaccination card with vit A]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Proportion of fully vaccinated children (similar in all groups)</bold>
<break/>
<bold>-Proportion of infants receiving catch-up vaccination [OPV 2 or 3, penta and/or PCV] (higher in both integration groups compared to control)</bold>
</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>-Coverage of vit A supplement (higher in both integration groups compared to control)</bold>
<break/>
<bold>-Provision of FP counseling and commodities (higher in both integration groups compared to control)</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> the last name of the first author and the publication year; studies are ordered by linked maternal and child health service, and then alphabetically by author. Notes: ANC = antenatal care; BCG = bacille Calmette&#x02013;Guerin vaccine; EPI = expanded program of immunizations; FP = family planning; IMCI = integrated management of childhood illnesses; IPV = inactivated polio vaccine; IYCF = infant and young child feeding; MCH = maternal and child health;; OPV = oral polio vaccine; PHC = primary healthcare; PCV = pneumococcal conjugate vaccine; Penta = pentavalent; PNC = prenatal care; vit A = vitamin A supplementation; WASH = water, sanitation, and hygiene.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec3dot3-vaccines-12-01313"><title>3.3. Integration Strategies</title><p>Almost half (44%) of the included studies reported the use of multiple strategies for integrated service delivery (<xref rid="vaccines-12-01313-t004" ref-type="table">Table 4</xref>). The most frequently described strategies were the co-location of services (<italic toggle="yes">n</italic> = 23 studies, 68%), the provision of extra services by immunization staff (<italic toggle="yes">n</italic> = 14, 41%), the provision of extra information and/or counseling by immunization staff (<italic toggle="yes">n</italic> = 14, 41%), and the provision of extra information and/or counseling by non-immunization staff (<italic toggle="yes">n</italic> = 4, 12%). No studies reported on vaccination services provided by staff whose job description did not usually include vaccination.</p><p>In general, there was no clear pattern in the types of strategy used to integrate particular linked MCH services (<xref rid="vaccines-12-01313-t001" ref-type="table">Table 1</xref>, <xref rid="vaccines-12-01313-t002" ref-type="table">Table 2</xref>, <xref rid="vaccines-12-01313-t003" ref-type="table">Table 3</xref> and <xref rid="vaccines-12-01313-t004" ref-type="table">Table 4</xref>). However, it was noted that the provision of &#x02018;extra services by immunization staff&#x02019; was one of the integration strategies described in 88% (7 of 8) of malaria studies [<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01313" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01313" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01313" ref-type="bibr">55</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>] and the provision of &#x02018;extra information and/or counselling by immunization staff&#x02019; was one of the strategies described in 78% (7 of 9) of family planning studies [<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>].</p></sec><sec id="sec3dot4-vaccines-12-01313"><title>3.4. Effect of Integration on Outcomes for Immunization and Linked Service</title><p>Most of the included studies (<italic toggle="yes">n</italic> = 25, 74%) reported at least one immunization (<italic toggle="yes">n</italic> = 20) and/or linked health service outcome (<italic toggle="yes">n</italic> = 21) that could be compared across groups with and without the implementation of integrated service delivery (<xref rid="vaccines-12-01313-t005" ref-type="table">Table 5</xref>). Data on immunization outcomes included vaccination coverage for one or more antigens or the proportion of children who were fully vaccinated (<italic toggle="yes">n</italic> = 11, 55%), the number of doses for one or more antigen (<italic toggle="yes">n</italic> = 7, 35%), and drop-out rates (<italic toggle="yes">n</italic> = 2, 10%). For linked MCH services, the reported outcomes either described the coverage of the service (<italic toggle="yes">n</italic> = 14, 67%) or the number of participants accessing/using the service (<italic toggle="yes">n</italic> = 7, 33%). Overall, the effect of integration was beneficial (mixed positive or positive) for most (76%) studies reporting linked MCH service outcomes and nearly half (55%) of studies reporting immunization outcomes.</p><p>For most studies that reported both immunization service and linked health service outcomes (<italic toggle="yes">n</italic> = 16), the relative boost in coverage or uptake obtained for the linked MCH service was generally the same or better than the effect on the immunization outcome. No clear relationship was observed between the integration strategy and the effect when grouped by immunization delivery platform and linked health service (<xref rid="vaccines-12-01313-t005" ref-type="table">Table 5</xref>).</p><p>Among studies that integrated service delivery during immunization campaigns (<italic toggle="yes">n</italic> = 3), groups receiving integrated services had significantly higher vaccination coverage for measles [<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>] and oral polio vaccine (OPV) [<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>], and significantly higher long-lasting insecticide-treated (ITN) bednet coverage [<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>], compared to non-integrated service delivery groups (<xref rid="vaccines-12-01313-t005" ref-type="table">Table 5</xref>).</p><p>For studies of the integration of family planning services with routine immunization service delivery (<italic toggle="yes">n</italic> = 7), the effect on vaccination coverage was static. The exception was the work of Cooper, 2020 [<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>], which showed a mixed positive effect based on the static coverage of DTP1 but elevated coverage of DTP3. Across the same studies [<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>], the effect on family planning service outcomes ranged from static to positive (<xref rid="vaccines-12-01313-t005" ref-type="table">Table 5</xref>).</p><p>The effect on outcomes was more variable in the seven studies integrating HIV services with routine immunization service delivery [<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>]. The three studies reporting immunization outcomes showed mixed negative [<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>], static (48), or positive [<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>] effects on either vaccination coverage or the number of doses administered. The four studies reporting linked health service outcomes indicated mostly positive effects [<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>], but one negative (45) effect, on outcomes related to early infant diagnosis of HIV (<xref rid="vaccines-12-01313-t005" ref-type="table">Table 5</xref>).</p><p>Among the six studies integrating malaria interventions with routine immunization service delivery [<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B54-vaccines-12-01313" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01313" ref-type="bibr">55</xref>], the direction of the effect on outcomes varied. However, within studies, there was some consistency in the outcome effects on both the immunization and linked MCH services. Bojang (2011) [<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>] reported the negative effects of integration on both fully vaccinated coverage and the coverage of intermittent preventative treatment for malaria in children (IPTc) and Dicko (2011) [<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>] reported positive effects on both fully vaccinated coverage and the coverage of IPT during infancy (IPTi). Schellenberg (2011) and Wiley (2011) [<xref rid="B54-vaccines-12-01313" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01313" ref-type="bibr">55</xref>] reported a static effect on DTP3 and measles vaccination coverage, but a positive effect on IPTi. Patouillard (2011) [<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>] did not measure immunization outcomes and reported a static effect of integration on IPTc (<xref rid="vaccines-12-01313-t005" ref-type="table">Table 5</xref>).</p><p>Two studies of the integration of nutrition services with routine immunization service delivery only reported outcomes related to either immunization or linked health services. Monterrosa (2013) [<xref rid="B60-vaccines-12-01313" ref-type="bibr">60</xref>] reported the positive effect of integration on the frequency of breastfeeding and Oladeji (2019) [<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>] reported a positive improvement in from Penta 1 to Penta 3 drop-out rates in the integrated group (<xref rid="vaccines-12-01313-t005" ref-type="table">Table 5</xref>).</p><p>Two studies focused on the integration of WASH services with immunization services. Briere (2012) and Ryman 2012 [<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>] both reported statistically significant increases in the proportion of fully vaccinated children, and increases in WASH outcomes such as awareness and the uptake of water treatment options in the integrated service delivery group compared to the non-integrated delivery group (<xref rid="vaccines-12-01313-t005" ref-type="table">Table 5</xref>).</p><p>For the four studies integrating multiple services with routine immunization service delivery [<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>,<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-12-01313" ref-type="bibr">24</xref>], the effects of integration on immunization outcomes and linked service outcomes were either mixed positive or positive (<xref rid="vaccines-12-01313-t005" ref-type="table">Table 5</xref>).</p></sec><sec id="sec3dot5-vaccines-12-01313"><title>3.5. Implementation Considerations</title><p>The processes, enablers, and barriers affecting service integration, as described by the included studies, are shown in <xref rid="vaccines-12-01313-t006" ref-type="table">Table 6</xref>.</p><p>In relation to policy and governance, the key themes that emerged were the consistency of national government support and policies for integration [<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>,<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>]; the pursuit of efficiency in the delivery of health services by governments and donors, in particular for campaigns [<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>]; and the expansion of policies to minimize the financial burden of integration within primary healthcare services [<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>] (<xref rid="vaccines-12-01313-t006" ref-type="table">Table 6</xref>).</p><p>Several studies discussed the re-design of services in a way best suited to promote integration. One frequently mentioned consideration was the need for the co-location in place and time of additional staff, particularly if the linked service was time-consuming or needed specialized skills [<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>]. Additionally, studies also noted that integrated approaches should consider the compatibility of cadence for services, target groups, and types of services [<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>]; McCollum (2012) [<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>] noted that the integration of HIV preventative services with immunization may be more beneficial than treatment due to the better prognoses obtained when initiating care as early as possible. Studies also reported that the process of integration should not compromise the uptake or quality of services [<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>,<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>]. Integration was also sometimes viewed as an opportunity to provide services, especially with the help of community health workers, to areas or communities that are hard to reach, thus expanding the reach of services [<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>] (<xref rid="vaccines-12-01313-t006" ref-type="table">Table 6</xref>).</p><p>Most studies mentioned one or more considerations relating to human resources for health that affect the success of integrated service delivery. The training needs highlighted included the benefit of harmonized combined training for vaccinators and linked health services providers [<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-12-01313" ref-type="bibr">24</xref>,<xref rid="B27-vaccines-12-01313" ref-type="bibr">27</xref>,<xref rid="B29-vaccines-12-01313" ref-type="bibr">29</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B54-vaccines-12-01313" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01313" ref-type="bibr">55</xref>], additional training on communications to improve community understanding and the uptake of integrated activities [<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>], and training focused on integration processes and tools [<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>]. The management of staff workloads and the time required for additional tasks were also major concerns reported in many studies [<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>,<xref rid="B29-vaccines-12-01313" ref-type="bibr">29</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01313" ref-type="bibr">53</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>,<xref rid="B60-vaccines-12-01313" ref-type="bibr">60</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]. There was recognition that integration may require additional staff with specific skillsets [<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>,<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>]. Other considerations mentioned were the importance of involving community-based health workers in efforts to support integrated service delivery [<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B24-vaccines-12-01313" ref-type="bibr">24</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>], improved motivation, the empowerment of healthcare staff to provide expanded care, which healthcare workers generally perceived as better in terms of quality and responsiveness [<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>], and ensuring that staff involved in integration were willing to collaborate in order to provide the additional services [<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>] (<xref rid="vaccines-12-01313-t006" ref-type="table">Table 6</xref>). In terms of management, logistics, and costs, the consistent availability of supplies and commodities, particularly for the linked service, and coordinated logistics were mentioned frequently, with some studies noting that stockouts could be a deterrent for clients returning for care or services [<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B30-vaccines-12-01313" ref-type="bibr">30</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]. Particularly for more sensitive linked services, such as HIV or family planning, studies noted that it was important to ensure that infrastructure for service delivery was supportive and appropriate regarding considerations such as privacy needs [<xref rid="B29-vaccines-12-01313" ref-type="bibr">29</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>]. Additionally, although some studies suggested that improving efficiencies could reduce the costs of integrated service delivery [<xref rid="B27-vaccines-12-01313" ref-type="bibr">27</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>], one study noted that integration involving professional staff may, in fact, increase costs [<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>] (<xref rid="vaccines-12-01313-t003" ref-type="table">Table 3</xref>). Studies noted the need for new systems for reporting and recording integrated service delivery. Other considerations included new tools, such as job aids to support staff in providing integrated care or other operational aspects of integration [<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>]. There were also reports of the need to account for the additional workload in expanded information and reporting systems [<xref rid="B29-vaccines-12-01313" ref-type="bibr">29</xref>,<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>], including home-based records, and ensure adequate time is taken to record and report additional services [<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>] (<xref rid="vaccines-12-01313-t006" ref-type="table">Table 6</xref>).</p><p>Many studies reported the importance of addressing community and client considerations during service re-design; specifically, there was a need for some consideration of how integrated services would be perceived and the degree to which they would be seen as more responsive to clients&#x02019; needs [<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-12-01313" ref-type="bibr">24</xref>,<xref rid="B27-vaccines-12-01313" ref-type="bibr">27</xref>,<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>,<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]. The need for clear communications through multiple channels was reported in some studies [<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>]. In scenarios where linked services were potentially sensitive, such as for HIV diagnosis or care, integration efforts needed to address potential stigma [<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B58-vaccines-12-01313" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01313" ref-type="bibr">59</xref>], and for some, like family planning, they needed consider how to account for clients&#x02019; preferences in terms of involving a spouse in decision-making [<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>]. Clients, like providers, were concerned that integrating services should not unreasonably increase the time or costs of care seeking [<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]. Many studies did consider the degree to which more integrated services could address common constraints on care seeking, and this was reported as an important motivator for pursuing health service integration [<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>,<xref rid="B27-vaccines-12-01313" ref-type="bibr">27</xref>,<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>] (<xref rid="vaccines-12-01313-t006" ref-type="table">Table 6</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-vaccines-12-01313"><title>4. Discussion</title><p>In this systematic review update of the integration of MCH services with childhood immunization services, we synthesized evidence from 34 relevant studies, which were identified between 2011 and 2020, following the publication of the last review on this topic in 2012 [<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>]. In comparison to previous reviews [<xref rid="B4-vaccines-12-01313" ref-type="bibr">4</xref>,<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>], there were fewer articles included reporting on the integration of service delivery within immunization campaigns. With more recent global strategies calling for a shift towards integrated campaigns beyond the co-delivery of multiple vaccine antigens [<xref rid="B64-vaccines-12-01313" ref-type="bibr">64</xref>], evidence from integrated service delivery in campaigns will be important for informing these approaches. Although a similar range of linked services was observed in this review as in the previous reviews [<xref rid="B4-vaccines-12-01313" ref-type="bibr">4</xref>,<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>], the current review included a larger proportion of family planning studies. Additionally, despite recent global initiatives calling for integrated service delivery within primary healthcare structures [<xref rid="B1-vaccines-12-01313" ref-type="bibr">1</xref>,<xref rid="B2-vaccines-12-01313" ref-type="bibr">2</xref>,<xref rid="B8-vaccines-12-01313" ref-type="bibr">8</xref>], most included studies focused on malaria, family planning, and HIV, suggesting that the implementation of integrated service delivery may be driven by specific programs or funded initiatives rather than by a push towards achieving universal health coverage. The considerable heterogeneity of study designs reflects the challenges of conducting real-world implementation research into modifications to service delivery, especially in low-resource settings.</p><p>Our review assessed the effect of integrated service delivery on outcomes for immunization and/or linked health services. Among 16 included studies where both outcomes were reported, the effect of integration on the linked health service was generally equal to or showed greater benefit than the effect on immunization; additionally, the effect on immunization was only negative in one study where both outcomes were reported. This result supports previous observations that the coverage of other health services could be expanded through integrated service delivery with immunization programs. This was described, for example, in reviews from 2015 relating to interventions for HIV [<xref rid="B65-vaccines-12-01313" ref-type="bibr">65</xref>] and family planning [<xref rid="B66-vaccines-12-01313" ref-type="bibr">66</xref>]. In these, and in our synthesis, the extent of benefit was likely to depend on the strength of the immunization platform prior to integration [<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>] and on the successful management of implementation considerations. Positive outcomes were not universal: we found two studies in which integrated service delivery had poorer outcomes for the linked service when compared to alternatives for both HIV [<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>] and malaria [<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>]; immunization outcomes were not reported in either of these studies. For both studies, there were different processes contributing to the lack of benefit to linked health services from integration. In the HIV study [<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>], immunization clinics yielded the lowest percentage of eligible children for pediatric HIV testing in comparison with other points of service, possibly due to the lower overlap of the target age range for immunization clinics and pediatric HIV testing (0&#x02013;14 years). In the malaria study [<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>], the coverage of IPTc was higher when delivered by village health workers compared to monthly delivery by reproductive and child health trekking teams, which included EPI staff. This may have been due to the convenience of community-based antimalarial delivery, which is available any day of the month rather than on scheduled EPI delivery days. In one study, which integrated family planning with immunization [<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>] and did not see increased contraceptive uptake, a lack of fidelity in implementation was assessed as the likely cause. Community perceptions appear to play an important role, with caution seen when HIV service referrals are integrated with immunization visits [<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>], and enthusiasm seen when immunization is linked to malaria control [<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>].</p><p>The previous reviews [<xref rid="B4-vaccines-12-01313" ref-type="bibr">4</xref>,<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>] highlighted challenges with integration including, logistical difficulties, concerns with harming existing services, target age group differences, and pre-existing low immunization coverage. Key lessons learned for service delivery integration included the importance of establishing intervention compatibility, considering the current immunization program&#x02019;s strength when choosing to integrate, and ensuring strong planning for integration. In this review, almost all studies noted the critical importance of the details of implementation in determining whether an attempt to integrate services proves beneficial. The considerations summarized in <xref rid="vaccines-12-01313-t003" ref-type="table">Table 3</xref> provide a framework that can be drawn on by planners wishing to promote greater service integration. Our synthesis suggests that three key areas determine how easy it is to integrate services, and thus contribute to improved service delivery: firstly, whether there is a good alignment of the new linked services&#x02019; target population and the need for skills and supplies with the capacities of the service platform already in use for immunization; secondly, whether investments are in place to adequately support staff in terms of the guidance, training, time, supplies, and workforce needed to deliver the expanded package of care; and thirdly, whether clients&#x02019; expectations (for example privacy or timely care) are met and community perceptions are well understood, which can be achieved through formative assessment if necessary. These areas were not demonstrated in all included studies, and relatively fewer studies fully accounted for the client perspective; therefore, this represents our synthesis of the factors that correlated with beneficial outcomes.</p><p>In this review, we observed a range of integration processes, such as child health screening; the provision of referrals, counseling, or testing; and the distribution of commodities or medicines. We broadly classified these into types of strategies, such as the provision of extra services or information by immunization or non-immunization staff, and the co-location or timing of service delivery. Most studies reported the use of a combination of these strategies in the integration process, with co-location and the provision of extra services by immunization staff being the most common. The feasibility of the integration strategy depends on the complexity of the linked health service and the EPI platform used for delivery; for instance, easy-to-administer commodities such as ITNs or medicines such as de-worming treatment may be more conducive to extra service provision by immunization staff, either during immunization campaigns or at routine immunization contact points, but more time-intensive and potentially sensitive processes such as counseling for HIV testing and treatment may be better suited to delivery during routine immunization services [<xref rid="B5-vaccines-12-01313" ref-type="bibr">5</xref>]. Our evidence also suggests that the integration of complex tasks, especially those involving counseling or curative care, may be better handled by the co-location of additional staff at the same time and place as immunization services, rather than via the addition of these tasks to the work of vaccinators.</p><p>To enable a focus on integration outcomes, this review was limited to studies reporting on intentional efforts to implement and measure an explicit change to service delivery with the prime purpose of integrating other services with childhood immunization programs. We could not include broader approaches such as the integrated management of childhood illnesses, for which integration is one approach amongst several, as part of primary healthcare-strengthening initiatives; these may also provide valuable examples. Additionally, given this review&#x02019;s focus on integrated service delivery at immunization program contact points, we excluded studies reporting on missed opportunities for vaccination and integrated approaches to community health education, which are other key focus areas for integration with potential benefits to immunization coverage. Additionally, given the wide range of study designs and the heterogeneity of outcomes reported, we were unable to conduct a quantitative synthesis of effect measures.</p><p>Our review identified new articles published since the previous review on this topic [<xref rid="B6-vaccines-12-01313" ref-type="bibr">6</xref>], but several evidence gaps remain. First, there were few studies from LMICs outside of Africa; additional studies from a wider range of LMICs are needed, particularly from Asian and Pacific nations, given their large populations and/or the knowledge gaps. Second, many studies reporting on integrated campaigns did not include a non-integration comparator, thus limiting our ability to evaluate the effect of integrated service delivery; there is a pressing need to expand the documentation of integrated health campaigns, especially regarding their cost-effectiveness [<xref rid="B64-vaccines-12-01313" ref-type="bibr">64</xref>,<xref rid="B67-vaccines-12-01313" ref-type="bibr">67</xref>]. Third, although the cost-saving benefits of integrated services in general are sometimes cited [<xref rid="B1-vaccines-12-01313" ref-type="bibr">1</xref>], there were few studies reporting on the cost of integrated service delivery compared to the use of non-integrated approaches. Fourth, evidence gaps persist surrounding the role of client preferences for integrated service delivery, including which services to integrate, at what contact points, and how, in the design of integrated approaches. Relatively few of the studies we reviewed included community members&#x02019; preferences in the design of integrated services. Finally, future implementation research should focus on integrated service delivery in the context of new vaccine introduction, in particular for older age groups beyond the first two years of life. More recently introduced vaccines a in adolescence, such as those against the human papillomavirus (HPV), present a new range of opportunities for integrating other services; these vary considerably by service delivery platform, with different options for integration during school-based vaccination to those available from facility- or community-based services [<xref rid="B68-vaccines-12-01313" ref-type="bibr">68</xref>].</p></sec><sec sec-type="conclusions" id="sec5-vaccines-12-01313"><title>5. Conclusions</title><p>Approaches to integrating MCH services with immunization programs have the potential to expand access to and the utilization of linked services and, in some cases, improve immunization coverage. The strategies and processes for integration varied across studies, and were typically determined by the nature of the linked health service. The details of service design and implementation were found to be critical determinants of the success of integration. Integrated services continue to play an important role in achieving more client-centered services in primary healthcare and progress towards IA2030. Future implementation research should expand the focus of integrated service delivery by taking a life-course approach that examines opportunities for expanded care during immunization services offered at broader age ranges.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to dedicate this article to Vance Dietz and his lifelong work in immunizations, including his support for and expertise on integration. Dietz was the senior author for both of the previous publications on this topic and his contributions to this field will be greatly missed. The authors also gratefully acknowledge early contributions to the design of this review from Beverley Biggs, Patrick Condron, Freya Fowkes, Kathleen Fox, Tracey Goodman, John Stanback, Margaret Watkins and Emily Wootton. Burnet Institute is located on the traditional lands of the Boon Wurrung people of the Kulin Nations and we pay our respects to their elders past and present.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vaccines-12-01313"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at <uri xlink:href="https://www.mdpi.com/article/10.3390/vaccines12121313/s1">https://www.mdpi.com/article/10.3390/vaccines12121313/s1</uri>. Table S1: List of studies excluded on full-text review and reason for exclusion (<italic toggle="yes">n</italic> = 427).</p><supplementary-material id="vaccines-12-01313-s001" position="float" content-type="local-data"><media xlink:href="vaccines-12-01313-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, C.J.M. and A.S.W., with input from J.G.B. and B.M.; methodology, C.J.M. and A.S.W., with input from J.G.B. and B.M.; validation, C.J.M., M.P.S. and A.S.W.; formal analysis, M.P.S., C.J.M. and A.S.W.; investigation, C.J.M., E.P., J.D., M.P.S. and A.S.W.; data curation, M.P.S. and C.J.M.; writing&#x02014;original draft preparation, M.P.S., C.J.M. and A.S.W.; writing&#x02014;review and editing, all authors (A.S.W., B.M., C.J.M., E.P., J.D., J.G.B. and M.P.S.); visualization, M.P.S. and C.J.M.; supervision, J.G.B. and B.M.; funding acquisition, C.J.M. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in the article/<xref rid="app1-vaccines-12-01313" ref-type="app">Supplementary Materials</xref>. Further inquiries can be directed to the corresponding author(s).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.</p></notes><ref-list><title>References</title><ref id="B1-vaccines-12-01313"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>Immunization Agenda Partners</collab>
</person-group><article-title>Immunization agenda 2030: A global strategy to leave no one behind</article-title><source>Vaccine</source><year>2024</year><volume>42</volume><issue>(Suppl. 1)</issue><fpage>S5</fpage><lpage>S14</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2022.11.042</pub-id><pub-id pub-id-type="pmid">39004466</pub-id>
</element-citation></ref><ref id="B2-vaccines-12-01313"><label>2.</label><element-citation publication-type="webpage"><article-title>Universal Health Coverage (UHC): World Health Organization: Geneva. Updated 5 October 2023</article-title><comment>Available online: <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc)" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc)</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-08-16">(accessed on 16 August 2024)</date-in-citation></element-citation></ref><ref id="B3-vaccines-12-01313"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>WHO &#x00026; UNICEF</collab>
</person-group><source>Tracking Progress Towards Universal Coverage for Reproductive, Newborn and Child Health: The 2017 Report</source><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2017</year></element-citation></ref><ref id="B4-vaccines-12-01313"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wallace</surname><given-names>A.</given-names></name>
<name><surname>Dietz</surname><given-names>V.</given-names></name>
<name><surname>Cairns</surname><given-names>K.L.</given-names></name>
</person-group><article-title>Integration of immunization services with other health interventions in the developing world: What works and why? Systematic literature review</article-title><source>Trop. Med. Int. Health</source><year>2009</year><volume>14</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3156.2008.02196.x</pub-id><pub-id pub-id-type="pmid">19017307</pub-id>
</element-citation></ref><ref id="B5-vaccines-12-01313"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wallace</surname><given-names>A.</given-names></name>
<name><surname>Ryman</surname><given-names>T.</given-names></name>
<name><surname>Mihigo</surname><given-names>R.</given-names></name>
<name><surname>Ndoutabe</surname><given-names>M.</given-names></name>
<name><surname>Tounkara</surname><given-names>B.</given-names></name>
<name><surname>Grant</surname><given-names>G.</given-names></name>
<name><surname>Anya</surname><given-names>B.</given-names></name>
<name><surname>Kiawi</surname><given-names>E.C.</given-names></name>
<name><surname>Kone</surname><given-names>S.</given-names></name>
<name><surname>Tesfaye</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Strengthening evidence-based planning of integrated health service delivery through local measures of health intervention delivery times</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>205</volume><issue>(Suppl. 1)</issue><fpage>S40</fpage><lpage>S48</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir775</pub-id><pub-id pub-id-type="pmid">22315385</pub-id>
</element-citation></ref><ref id="B6-vaccines-12-01313"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wallace</surname><given-names>A.S.</given-names></name>
<name><surname>Ryman</surname><given-names>T.K.</given-names></name>
<name><surname>Dietz</surname><given-names>V.</given-names></name>
</person-group><article-title>Experiences integrating delivery of maternal and child health services with childhood immunization programs: Systematic review update</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>205</volume><issue>(Suppl. 1)</issue><fpage>S6</fpage><lpage>S19</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir778</pub-id><pub-id pub-id-type="pmid">22315388</pub-id>
</element-citation></ref><ref id="B7-vaccines-12-01313"><label>7.</label><element-citation publication-type="book"><source>Working Together: An Integration Resource Guide for Immunization Services Throughout the Life Course</source><comment>Contract No.: Licence: CC BY-NCSA 3.0 IGO</comment><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2018</year></element-citation></ref><ref id="B8-vaccines-12-01313"><label>8.</label><element-citation publication-type="confproc"><article-title>The Lusaka Agenda: Conclusions of the Future of Global Health Initiatives Process</article-title><source>Proceedings of the Future Global Health Initiatives</source><conf-loc>Addis Ababa, Ethiopia</conf-loc><conf-date>14 June 2024</conf-date></element-citation></ref><ref id="B9-vaccines-12-01313"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wallace</surname><given-names>A.S.</given-names></name>
<name><surname>Ryman</surname><given-names>T.K.</given-names></name>
<name><surname>Privor-Dumm</surname><given-names>L.</given-names></name>
<name><surname>Morgan</surname><given-names>C.</given-names></name>
<name><surname>Fields</surname><given-names>R.</given-names></name>
<name><surname>Garcia</surname><given-names>C.</given-names></name>
<name><surname>Sodha</surname><given-names>S.V.</given-names></name>
<name><surname>Lindstrand</surname><given-names>A.</given-names></name>
<name><surname>Nic Lochlainn</surname><given-names>L.M.</given-names></name>
</person-group><article-title>Leaving no one behind: Defining and implementing an integrated life course approach to vaccination across the next decade as part of the immunization Agenda 2030</article-title><source>Vaccine</source><year>2024</year><volume>42</volume><issue>(Suppl. 1)</issue><fpage>S54</fpage><lpage>S63</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2022.11.039</pub-id><pub-id pub-id-type="pmid">36503859</pub-id>
</element-citation></ref><ref id="B10-vaccines-12-01313"><label>10.</label><element-citation publication-type="book"><source>The Big Catch-Up: An Essential Immunization Recovery Plan for 2023 and Beyond</source><publisher-name>WHO</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2023</year></element-citation></ref><ref id="B11-vaccines-12-01313"><label>11.</label><element-citation publication-type="webpage"><article-title>Cochrane Effective Practice and Organisation of Care (EPOC)</article-title><comment>Available online: <ext-link xlink:href="https://epoc.cochrane.org/" ext-link-type="uri">https://epoc.cochrane.org/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-09-09">(accessed on 9 September 2024)</date-in-citation></element-citation></ref><ref id="B12-vaccines-12-01313"><label>12.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>C.J.</given-names></name>
<name><surname>Davis</surname><given-names>J.</given-names></name>
<name><surname>Watkins</surname><given-names>M.</given-names></name>
<name><surname>Wallace</surname><given-names>A.</given-names></name>
<name><surname>Fox</surname><given-names>F.</given-names></name>
<name><surname>Goodman</surname><given-names>T.</given-names></name>
<name><surname>Stanback</surname><given-names>J.</given-names></name>
<name><surname>Fowkes</surname><given-names>F.</given-names></name>
<name><surname>Condron</surname><given-names>P.</given-names></name>
<name><surname>Biggs</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Integration of Immunisation Services and Other Health Services in Low- and Middle-Income Countries: Protocol for an Updated Systematic Review: CRD420160458762016</article-title><comment>Available online: <ext-link xlink:href="https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42016045876" ext-link-type="uri">https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42016045876</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-11-15">(accessed on 15 November 2024)</date-in-citation></element-citation></ref><ref id="B13-vaccines-12-01313"><label>13.</label><element-citation publication-type="webpage"><article-title>The World by Income and Region, 2016: The World Bank Group</article-title><comment>Available online: <ext-link xlink:href="https://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html" ext-link-type="uri">https://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-09-09">(accessed on 9 September 2024)</date-in-citation></element-citation></ref><ref id="B14-vaccines-12-01313"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>McKenzie</surname><given-names>J.E.</given-names></name>
<name><surname>Bossuyt</surname><given-names>P.M.</given-names></name>
<name><surname>Boutron</surname><given-names>I.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.C.</given-names></name>
<name><surname>Mulrow</surname><given-names>C.D.</given-names></name>
<name><surname>Shamseer</surname><given-names>L.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.M.</given-names></name>
<name><surname>Akl</surname><given-names>E.A.</given-names></name>
<name><surname>Brennan</surname><given-names>S.E.</given-names></name>
<etal/>
</person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id>
</element-citation></ref><ref id="B15-vaccines-12-01313"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balshem</surname><given-names>H.</given-names></name>
<name><surname>Helfand</surname><given-names>M.</given-names></name>
<name><surname>Sch&#x000fc;nemann</surname><given-names>H.J.</given-names></name>
<name><surname>Oxman</surname><given-names>A.D.</given-names></name>
<name><surname>Kunz</surname><given-names>R.</given-names></name>
<name><surname>Brozek</surname><given-names>J.</given-names></name>
<name><surname>Vist</surname><given-names>G.E.</given-names></name>
<name><surname>Falck-Ytter</surname><given-names>Y.</given-names></name>
<name><surname>Meerpohl</surname><given-names>J.</given-names></name>
<name><surname>Norris</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>GRADE guidelines: 3. Rating the quality of evidence</article-title><source>J. Clin. Epidemiol.</source><year>2011</year><volume>64</volume><fpage>401</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.07.015</pub-id><pub-id pub-id-type="pmid">21208779</pub-id>
</element-citation></ref><ref id="B16-vaccines-12-01313"><label>16.</label><element-citation publication-type="book"><source>Critical Appraisal Skills Programme (CASP) Qualitative Checklist</source><publisher-name>Critical Appraisal Skills Programme</publisher-name><publisher-loc>Oxford, UK</publisher-loc><year>2014</year></element-citation></ref><ref id="B17-vaccines-12-01313"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mays</surname><given-names>N.</given-names></name>
<name><surname>Pope</surname><given-names>C.</given-names></name>
<name><surname>Popay</surname><given-names>J.</given-names></name>
</person-group><article-title>Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field</article-title><source>J. Health Serv. Res. Policy</source><year>2005</year><volume>10</volume><issue>(Suppl. 1)</issue><fpage>6</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1258/1355819054308576</pub-id><pub-id pub-id-type="pmid">16053580</pub-id>
</element-citation></ref><ref id="B18-vaccines-12-01313"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Snilstveit</surname><given-names>B.</given-names></name>
<name><surname>Oliver</surname><given-names>S.</given-names></name>
<name><surname>Vojtkova</surname><given-names>M.</given-names></name>
</person-group><article-title>Narrative approaches to systematic review and synthesis of evidence for international development policy and practice</article-title><source>J. Dev. Effect.</source><year>2012</year><volume>4</volume><fpage>409</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1080/19439342.2012.710641</pub-id></element-citation></ref><ref id="B19-vaccines-12-01313"><label>19.</label><element-citation publication-type="book"><source>SURE Guides for Preparing and Using Evidence-Based Policy Briefs</source><comment>SURE Collaboration</comment><publisher-name>Norwegian Knowledge Center for the Health Services</publisher-name><publisher-loc>Oslo, Norway</publisher-loc><year>2011</year></element-citation></ref><ref id="B20-vaccines-12-01313"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bawa</surname><given-names>S.</given-names></name>
<name><surname>McNab</surname><given-names>C.</given-names></name>
<name><surname>Nkwogu</surname><given-names>L.</given-names></name>
<name><surname>Braka</surname><given-names>F.</given-names></name>
<name><surname>Obinya</surname><given-names>E.</given-names></name>
<name><surname>Galway</surname><given-names>M.</given-names></name>
<name><surname>Mirelman</surname><given-names>A.J.</given-names></name>
<name><surname>Hammanyero</surname><given-names>K.I.</given-names></name>
<name><surname>Safiyanu</surname><given-names>G.</given-names></name>
<name><surname>Chukwuji</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Using the polio programme to deliver primary health care in Nigeria: Implementation research</article-title><source>Bull. World Health Organ.</source><year>2019</year><volume>97</volume><fpage>24</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.2471/BLT.18.211565</pub-id><pub-id pub-id-type="pmid">30618462</pub-id>
</element-citation></ref><ref id="B21-vaccines-12-01313"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bawa</surname><given-names>S.</given-names></name>
<name><surname>Shuaib</surname><given-names>F.</given-names></name>
<name><surname>Saidu</surname><given-names>M.</given-names></name>
<name><surname>Ningi</surname><given-names>A.</given-names></name>
<name><surname>Abdullahi</surname><given-names>S.</given-names></name>
<name><surname>Abba</surname><given-names>B.</given-names></name>
<name><surname>Idowu</surname><given-names>A.</given-names></name>
<name><surname>Alkasim</surname><given-names>J.</given-names></name>
<name><surname>Hammanyero</surname><given-names>K.</given-names></name>
<name><surname>Warigon</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Conduct of vaccination in hard-to-reach areas to address potential polio reservoir areas, 2014-2015</article-title><source>BMC Public Health</source><year>2018</year><volume>18</volume><issue>(Suppl. 4)</issue><elocation-id>1312</elocation-id><pub-id pub-id-type="doi">10.1186/s12889-018-6194-y</pub-id><pub-id pub-id-type="pmid">30541501</pub-id>
</element-citation></ref><ref id="B22-vaccines-12-01313"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Edmond</surname><given-names>K.</given-names></name>
<name><surname>Yousufi</surname><given-names>K.</given-names></name>
<name><surname>Naziri</surname><given-names>M.</given-names></name>
<name><surname>Higgins-Steele</surname><given-names>A.</given-names></name>
<name><surname>Qadir</surname><given-names>A.Q.</given-names></name>
<name><surname>Sadat</surname><given-names>S.M.</given-names></name>
<name><surname>Bellows</surname><given-names>A.L.</given-names></name>
<name><surname>Smith</surname><given-names>E.</given-names></name>
</person-group><article-title>Mobile outreach health services for mothers and children in conflict-affected and remote areas: A population-based study from Afghanistan</article-title><source>Arch. Dis. Child.</source><year>2020</year><volume>105</volume><fpage>18</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1136/archdischild-2019-316802</pub-id><pub-id pub-id-type="pmid">31270097</pub-id>
</element-citation></ref><ref id="B23-vaccines-12-01313"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Habib</surname><given-names>M.A.</given-names></name>
<name><surname>Soofi</surname><given-names>S.</given-names></name>
<name><surname>Cousens</surname><given-names>S.</given-names></name>
<name><surname>Anwar</surname><given-names>S.</given-names></name>
<name><surname>Haque</surname><given-names>N.U.</given-names></name>
<name><surname>Ahmed</surname><given-names>I.</given-names></name>
<name><surname>Ali</surname><given-names>N.</given-names></name>
<name><surname>Tahir</surname><given-names>R.</given-names></name>
<name><surname>Bhutta</surname><given-names>Z.A.</given-names></name>
</person-group><article-title>Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: A cluster randomised controlled trial</article-title><source>Lancet Glob. Health</source><year>2017</year><volume>5</volume><fpage>e593</fpage><lpage>e603</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(17)30184-5</pub-id><pub-id pub-id-type="pmid">28495264</pub-id>
</element-citation></ref><ref id="B24-vaccines-12-01313"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hodges</surname><given-names>M.H.</given-names></name>
<name><surname>Sesay</surname><given-names>F.F.</given-names></name>
<name><surname>Kamara</surname><given-names>H.I.</given-names></name>
<name><surname>Nyorkor</surname><given-names>E.D.</given-names></name>
<name><surname>Bah</surname><given-names>M.</given-names></name>
<name><surname>Koroma</surname><given-names>A.S.</given-names></name>
<name><surname>Kandeh</surname><given-names>J.N.</given-names></name>
<name><surname>Ou&#x000e9;draogo</surname><given-names>R.</given-names></name>
<name><surname>Wolfe</surname><given-names>A.C.</given-names></name>
<name><surname>Katcher</surname><given-names>H.I.</given-names></name>
<etal/>
</person-group><article-title>Integrating Vitamin A Supplementation at 6 months into the Expanded Program of Immunization in Sierra Leone</article-title><source>Matern. Child Health J.</source><year>2015</year><volume>19</volume><fpage>1985</fpage><lpage>1992</lpage><pub-id pub-id-type="doi">10.1007/s10995-015-1706-1</pub-id><pub-id pub-id-type="pmid">25665894</pub-id>
</element-citation></ref><ref id="B25-vaccines-12-01313"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goodson</surname><given-names>J.L.</given-names></name>
<name><surname>Kulkarni</surname><given-names>M.A.</given-names></name>
<name><surname>Eng</surname><given-names>J.L.V.</given-names></name>
<name><surname>Wannemuehler</surname><given-names>K.A.</given-names></name>
<name><surname>Cotte</surname><given-names>A.H.</given-names></name>
<name><surname>Desrochers</surname><given-names>R.E.</given-names></name>
<name><surname>Randriamanalina</surname><given-names>B.</given-names></name>
<name><surname>Luman</surname><given-names>E.T.</given-names></name>
</person-group><article-title>Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar</article-title><source>Trop. Med. Int. Health</source><year>2012</year><volume>17</volume><fpage>430</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3156.2011.02953.x</pub-id><pub-id pub-id-type="pmid">22273490</pub-id>
</element-citation></ref><ref id="B26-vaccines-12-01313"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kulkarni</surname><given-names>M.A.</given-names></name>
<name><surname>Eng</surname><given-names>J.V.</given-names></name>
<name><surname>Desrochers</surname><given-names>R.E.</given-names></name>
<name><surname>Cotte</surname><given-names>A.H.</given-names></name>
<name><surname>Goodson</surname><given-names>J.L.</given-names></name>
<name><surname>Johnston</surname><given-names>A.</given-names></name>
<name><surname>Wolkon</surname><given-names>A.</given-names></name>
<name><surname>Erskine</surname><given-names>M.</given-names></name>
<name><surname>Berti</surname><given-names>P.</given-names></name>
<name><surname>Rakotoarisoa</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Contribution of integrated campaign distribution of long-lasting insecticidal nets to coverage of target groups and total populations in malaria-endemic areas in Madagascar</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2010</year><volume>82</volume><fpage>420</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0597</pub-id><pub-id pub-id-type="pmid">20207867</pub-id>
</element-citation></ref><ref id="B27-vaccines-12-01313"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boselli</surname><given-names>G.</given-names></name>
<name><surname>Yajima</surname><given-names>A.</given-names></name>
<name><surname>Aratchige</surname><given-names>P.E.</given-names></name>
<name><surname>Feldon</surname><given-names>K.E.</given-names></name>
<name><surname>Xeuatvongsa</surname><given-names>A.</given-names></name>
<name><surname>Phounphenghak</surname><given-names>K.</given-names></name>
<name><surname>Sihakhang</surname><given-names>K.</given-names></name>
<name><surname>Chitsavang</surname><given-names>C.</given-names></name>
<name><surname>Phengkeo</surname><given-names>S.</given-names></name>
<name><surname>Gabrielli</surname><given-names>A.F.</given-names></name>
<etal/>
</person-group><article-title>Integration of deworming into an existing immunisation and vitamin A supplementation campaign is a highly effective approach to maximise health benefits with minimal cost in Lao PDR</article-title><source>Int. Health</source><year>2011</year><volume>3</volume><fpage>240</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.inhe.2011.08.002</pub-id><pub-id pub-id-type="pmid">24038496</pub-id>
</element-citation></ref><ref id="B28-vaccines-12-01313"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Birukila</surname><given-names>G.</given-names></name>
<name><surname>Babale</surname><given-names>S.M.</given-names></name>
<name><surname>Epstein</surname><given-names>H.</given-names></name>
<name><surname>Gugong</surname><given-names>V.</given-names></name>
<name><surname>Anger</surname><given-names>R.</given-names></name>
<name><surname>Corkum</surname><given-names>M.</given-names></name>
<name><surname>Nebanat</surname><given-names>A.J.</given-names></name>
<name><surname>Musoke</surname><given-names>F.</given-names></name>
<name><surname>Alabi</surname><given-names>O.</given-names></name>
</person-group><article-title>Reducing resistance to polio immunisation with free health camps and Bluetooth messaging: An update from Kaduna, Northern, Nigeria</article-title><source>Glob. Public Health</source><year>2017</year><volume>12</volume><fpage>19</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1080/17441692.2016.1152283</pub-id><pub-id pub-id-type="pmid">26998877</pub-id>
</element-citation></ref><ref id="B29-vaccines-12-01313"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Friderichs</surname><given-names>N.</given-names></name>
<name><surname>Swanepoel</surname><given-names>D.</given-names></name>
<name><surname>Hall</surname><given-names>J.W.</given-names><suffix>3rd</suffix></name>
</person-group><article-title>Efficacy of a community-based infant hearing screening program utilizing existing clinic personnel in Western Cape, South Africa</article-title><source>Int. J. Pediatr. Otorhinolaryngol.</source><year>2012</year><volume>76</volume><fpage>552</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1016/j.ijporl.2012.01.015</pub-id><pub-id pub-id-type="pmid">22326208</pub-id>
</element-citation></ref><ref id="B30-vaccines-12-01313"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jac-Okereke</surname><given-names>C.A.</given-names></name>
<name><surname>Ezegwui</surname><given-names>I.R.</given-names></name>
<name><surname>Okoye</surname><given-names>O.</given-names></name>
</person-group><article-title>Vision Screening in Infants Attending Immunization Clinics in a Developing Country</article-title><source>J. Prim. Care Community Health</source><year>2020</year><volume>11</volume><fpage>2150132720907430</fpage><pub-id pub-id-type="doi">10.1177/2150132720907430</pub-id><pub-id pub-id-type="pmid">32100627</pub-id>
</element-citation></ref><ref id="B31-vaccines-12-01313"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balasubramaniam</surname><given-names>S.</given-names></name>
<name><surname>Kumar</surname><given-names>S.</given-names></name>
<name><surname>Sethi</surname><given-names>R.</given-names></name>
<name><surname>Charurat</surname><given-names>E.</given-names></name>
<name><surname>Lalchandani</surname><given-names>K.</given-names></name>
<name><surname>Schuster</surname><given-names>A.</given-names></name>
<name><surname>Sood</surname><given-names>B.</given-names></name>
</person-group><article-title>Quasi-experimental Study of Systematic Screening for Family Planning Services among Postpartum Women Attending Village Health and Nutrition Days in Jharkhand, India</article-title><source>Int. J. Integr. Care</source><year>2018</year><volume>18</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.5334/ijic.3078</pub-id><pub-id pub-id-type="pmid">29588642</pub-id>
</element-citation></ref><ref id="B32-vaccines-12-01313"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cooper</surname><given-names>C.M.</given-names></name>
<name><surname>Fields</surname><given-names>R.</given-names></name>
<name><surname>Mazzeo</surname><given-names>C.I.</given-names></name>
<name><surname>Taylor</surname><given-names>N.</given-names></name>
<name><surname>Pfitzer</surname><given-names>A.</given-names></name>
<name><surname>Momolu</surname><given-names>M.</given-names></name>
<name><surname>Jabbeh-Howe</surname><given-names>C.</given-names></name>
</person-group><article-title>Successful proof of concept of family planning and immunization integration in Liberia</article-title><source>Glob. Health Sci. Pract.</source><year>2015</year><volume>3</volume><fpage>71</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.9745/GHSP-D-14-00156</pub-id><pub-id pub-id-type="pmid">25745121</pub-id>
</element-citation></ref><ref id="B33-vaccines-12-01313"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cooper</surname><given-names>C.M.</given-names></name>
<name><surname>Wille</surname><given-names>J.</given-names></name>
<name><surname>Shire</surname><given-names>S.</given-names></name>
<name><surname>Makoko</surname><given-names>S.</given-names></name>
<name><surname>Tsega</surname><given-names>A.</given-names></name>
<name><surname>Schuster</surname><given-names>A.</given-names></name>
<name><surname>Hausi</surname><given-names>H.</given-names></name>
<name><surname>Gibson</surname><given-names>H.</given-names></name>
<name><surname>Tappis</surname><given-names>H.</given-names></name>
</person-group><article-title>Integrated Family Planning and Immunization Service Delivery at Health Facility and Community Sites in Dowa and Ntchisi Districts of Malawi: A Mixed Methods Process Evaluation</article-title><source>Int. J. Environ. Res. Public Health</source><year>2020</year><volume>17</volume><elocation-id>4530</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph17124530</pub-id><pub-id pub-id-type="pmid">32599688</pub-id>
</element-citation></ref><ref id="B34-vaccines-12-01313"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dulli</surname><given-names>L.S.</given-names></name>
<name><surname>Eichleay</surname><given-names>M.</given-names></name>
<name><surname>Rademacher</surname><given-names>K.</given-names></name>
<name><surname>Sortijas</surname><given-names>S.</given-names></name>
<name><surname>Nsengiyumva</surname><given-names>T.</given-names></name>
</person-group><article-title>Meeting Postpartum Women&#x02019;s Family Planning Needs Through Integrated Family Planning and Immunization Services: Results of a Cluster-Randomized Controlled Trial in Rwanda</article-title><source>Glob. Health Sci. Pract.</source><year>2016</year><volume>4</volume><fpage>73</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.9745/GHSP-D-15-00291</pub-id><pub-id pub-id-type="pmid">27016545</pub-id>
</element-citation></ref><ref id="B35-vaccines-12-01313"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Erhardt-Ohren</surname><given-names>B.</given-names></name>
<name><surname>Schroffel</surname><given-names>H.</given-names></name>
<name><surname>Rochat</surname><given-names>R.</given-names></name>
</person-group><article-title>Integrated Family Planning and Routine Child Immunization Services in Benin: A Process Evaluation</article-title><source>Matern. Child Health J.</source><year>2020</year><volume>24</volume><fpage>701</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1007/s10995-020-02915-5</pub-id><pub-id pub-id-type="pmid">32303937</pub-id>
</element-citation></ref><ref id="B36-vaccines-12-01313"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nelson</surname><given-names>A.R.</given-names></name>
<name><surname>Cooper</surname><given-names>C.M.</given-names></name>
<name><surname>Kamara</surname><given-names>S.</given-names></name>
<name><surname>Taylor</surname><given-names>N.D.</given-names></name>
<name><surname>Zikeh</surname><given-names>T.</given-names></name>
<name><surname>Kanneh-Kesselly</surname><given-names>C.</given-names></name>
<name><surname>Fields</surname><given-names>R.</given-names></name>
<name><surname>Hossain</surname><given-names>I.</given-names></name>
<name><surname>Oseni</surname><given-names>L.</given-names></name>
<name><surname>Getahun</surname><given-names>B.S.</given-names></name>
<etal/>
</person-group><article-title>Operationalizing Integrated Immunization and Family Planning Services in Rural Liberia: Lessons Learned from Evaluating Service Quality and Utilization</article-title><source>Glob. Health Sci Pract.</source><year>2019</year><volume>7</volume><fpage>418</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.9745/GHSP-D-19-00012</pub-id><pub-id pub-id-type="pmid">31558598</pub-id>
</element-citation></ref><ref id="B37-vaccines-12-01313"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vance</surname><given-names>G.</given-names></name>
<name><surname>Janowitz</surname><given-names>B.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Boyer</surname><given-names>B.</given-names></name>
<name><surname>Kasonde</surname><given-names>P.</given-names></name>
<name><surname>Asare</surname><given-names>G.</given-names></name>
<name><surname>Kafulubiti</surname><given-names>B.</given-names></name>
<name><surname>Stanback</surname><given-names>J.</given-names></name>
</person-group><article-title>Integrating family planning messages into immunization services: A cluster-randomized trial in Ghana and Zambia</article-title><source>Health Policy Plan.</source><year>2014</year><volume>29</volume><fpage>359</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1093/heapol/czt022</pub-id><pub-id pub-id-type="pmid">23570834</pub-id>
</element-citation></ref><ref id="B38-vaccines-12-01313"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Belemsaga</surname><given-names>D.Y.</given-names></name>
<name><surname>Goujon</surname><given-names>A.</given-names></name>
<name><surname>Bado</surname><given-names>A.</given-names></name>
<name><surname>Kouanda</surname><given-names>S.</given-names></name>
<name><surname>Duysburgh</surname><given-names>E.</given-names></name>
<name><surname>Temmerman</surname><given-names>M.</given-names></name>
<name><surname>Degomme</surname><given-names>O.</given-names></name>
</person-group><article-title>Integration of postpartum care into child health and immunization services in Burkina Faso: Findings from a cross-sectional study</article-title><source>Reprod. Health</source><year>2018</year><volume>15</volume><fpage>171</fpage><pub-id pub-id-type="doi">10.1186/s12978-018-0602-8</pub-id><pub-id pub-id-type="pmid">30305123</pub-id>
</element-citation></ref><ref id="B39-vaccines-12-01313"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yugbar&#x000e9; Belemsaga</surname><given-names>D.</given-names></name>
<name><surname>Goujon</surname><given-names>A.</given-names></name>
<name><surname>Degomme</surname><given-names>O.</given-names></name>
<name><surname>Nassa</surname><given-names>T.</given-names></name>
<name><surname>Duysburgh</surname><given-names>E.</given-names></name>
<name><surname>Kouanda</surname><given-names>S.</given-names></name>
<name><surname>Temmerman</surname><given-names>M.</given-names></name>
</person-group><article-title>Assessing changes in costs of maternal postpartum services between 2013 and 2014 in Burkina Faso</article-title><source>Int. J. Equity Health</source><year>2019</year><volume>18</volume><fpage>154</fpage><pub-id pub-id-type="doi">10.1186/s12939-019-1064-5</pub-id><pub-id pub-id-type="pmid">31615526</pub-id>
</element-citation></ref><ref id="B40-vaccines-12-01313"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yugbar&#x000e9; Belemsaga</surname><given-names>D.</given-names></name>
<name><surname>Goujon</surname><given-names>A.</given-names></name>
<name><surname>Tougri</surname><given-names>H.</given-names></name>
<name><surname>Coulibaly</surname><given-names>A.</given-names></name>
<name><surname>Degomme</surname><given-names>O.</given-names></name>
<name><surname>Duysburgh</surname><given-names>E.</given-names></name>
<name><surname>Temmerman</surname><given-names>M.</given-names></name>
<name><surname>Kouanda</surname><given-names>S.</given-names></name>
</person-group><article-title>Integration of maternal postpartum services in maternal and child health services in Kaya health district (Burkina Faso): An intervention time trend analysis</article-title><source>BMC Health Serv. Res.</source><year>2018</year><volume>18</volume><elocation-id>298</elocation-id><pub-id pub-id-type="doi">10.1186/s12913-018-3098-6</pub-id><pub-id pub-id-type="pmid">29685138</pub-id>
</element-citation></ref><ref id="B41-vaccines-12-01313"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dube</surname><given-names>Q.</given-names></name>
<name><surname>Dow</surname><given-names>A.</given-names></name>
<name><surname>Chirambo</surname><given-names>C.</given-names></name>
<name><surname>Lebov</surname><given-names>J.</given-names></name>
<name><surname>Tenthani</surname><given-names>L.</given-names></name>
<name><surname>Moore</surname><given-names>M.</given-names></name>
<name><surname>Heyderman</surname><given-names>R.</given-names></name>
<name><surname>Van Rie</surname><given-names>A.</given-names></name>
</person-group><article-title>Implementing early infant diagnosis of HIV infection at the primary care level: Experiences and challenges in Malawi</article-title><source>Bull. World Health Organ.</source><year>2012</year><volume>90</volume><fpage>699</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.2471/BLT.11.100776</pub-id><pub-id pub-id-type="pmid">22984315</pub-id>
</element-citation></ref><ref id="B42-vaccines-12-01313"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goodson</surname><given-names>J.L.</given-names></name>
<name><surname>Finkbeiner</surname><given-names>T.</given-names></name>
<name><surname>Davis</surname><given-names>N.L.</given-names></name>
<name><surname>Lyimo</surname><given-names>D.</given-names></name>
<name><surname>Rwebembera</surname><given-names>A.</given-names></name>
<name><surname>Swartzendruber</surname><given-names>A.L.</given-names></name>
<name><surname>Wallace</surname><given-names>A.S.</given-names></name>
<name><surname>Kimambo</surname><given-names>S.</given-names></name>
<name><surname>Kimario</surname><given-names>C.J.</given-names></name>
<name><surname>Wiktor</surname><given-names>S.Z.</given-names></name>
<etal/>
</person-group><article-title>Evaluation of using routine infant immunization visits to identify and follow-up HIV-exposed infants and their mothers in Tanzania</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2013</year><volume>63</volume><fpage>e9</fpage><lpage>e15</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e31828a3e3f</pub-id><pub-id pub-id-type="pmid">23406977</pub-id>
</element-citation></ref><ref id="B43-vaccines-12-01313"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wallace</surname><given-names>A.</given-names></name>
<name><surname>Kimambo</surname><given-names>S.</given-names></name>
<name><surname>Dafrossa</surname><given-names>L.</given-names></name>
<name><surname>Rusibamayila</surname><given-names>N.</given-names></name>
<name><surname>Rwebembera</surname><given-names>A.</given-names></name>
<name><surname>Songoro</surname><given-names>J.</given-names></name>
<name><surname>Arthur</surname><given-names>G.</given-names></name>
<name><surname>Luman</surname><given-names>E.</given-names></name>
<name><surname>Finkbeiner</surname><given-names>T.</given-names></name>
<name><surname>Goodson</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Qualitative assessment of the integration of HIV services with infant routine immunization visits in Tanzania</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2014</year><volume>66</volume><fpage>e8</fpage><lpage>e14</lpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000000078</pub-id><pub-id pub-id-type="pmid">24326602</pub-id>
</element-citation></ref><ref id="B44-vaccines-12-01313"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McCollum</surname><given-names>E.D.</given-names></name>
<name><surname>Johnson</surname><given-names>D.C.</given-names></name>
<name><surname>Chasela</surname><given-names>C.S.</given-names></name>
<name><surname>Siwande</surname><given-names>L.D.R.</given-names></name>
<name><surname>Kazembe</surname><given-names>P.N.M.</given-names></name>
<name><surname>Olson</surname><given-names>D.</given-names></name>
<name><surname>Hoffman</surname><given-names>I.P.</given-names></name>
<name><surname>van der Horst</surname><given-names>C.</given-names></name>
<name><surname>Hosseinipour</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Superior uptake and outcomes of early infant diagnosis of HIV services at an immunization clinic versus an &#x0201c;under-five&#x0201d; general pediatric clinic in Malawi</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2012</year><volume>60</volume><fpage>e107</fpage><lpage>e110</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e31825aa721</pub-id><pub-id pub-id-type="pmid">22614897</pub-id>
</element-citation></ref><ref id="B45-vaccines-12-01313"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Odafe</surname><given-names>S.</given-names></name>
<name><surname>Onotu</surname><given-names>D.</given-names></name>
<name><surname>Fagbamigbe</surname><given-names>J.O.</given-names></name>
<name><surname>Ene</surname><given-names>U.</given-names></name>
<name><surname>Rivadeneira</surname><given-names>E.</given-names></name>
<name><surname>Carpenter</surname><given-names>D.</given-names></name>
<name><surname>Omoigberale</surname><given-names>A.I.</given-names></name>
<name><surname>Adamu</surname><given-names>Y.</given-names></name>
<name><surname>Lawal</surname><given-names>I.</given-names></name>
<name><surname>James</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>Increasing pediatric HIV testing positivity rates through focused testing in high-yield points of service in health facilities-Nigeria, 2016&#x02013;2017</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0234717</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0234717</pub-id><pub-id pub-id-type="pmid">32559210</pub-id>
</element-citation></ref><ref id="B46-vaccines-12-01313"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ong&#x02019;ech</surname><given-names>J.O.</given-names></name>
<name><surname>Hoffman</surname><given-names>H.J.</given-names></name>
<name><surname>Kose</surname><given-names>J.</given-names></name>
<name><surname>Audo</surname><given-names>M.</given-names></name>
<name><surname>Matu</surname><given-names>L.</given-names></name>
<name><surname>Savosnick</surname><given-names>P.</given-names></name>
<name><surname>Guay</surname><given-names>L.</given-names></name>
</person-group><article-title>Provision of services and care for HIV-exposed infants: A comparison of maternal and child health clinic and HIV comprehensive care clinic models</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2012</year><volume>61</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e31825bd842</pub-id><pub-id pub-id-type="pmid">22592589</pub-id>
</element-citation></ref><ref id="B47-vaccines-12-01313"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tejiokem</surname><given-names>M.C.</given-names></name>
<name><surname>Faye</surname><given-names>A.</given-names></name>
<name><surname>Penda</surname><given-names>I.C.</given-names></name>
<name><surname>Guemkam</surname><given-names>G.</given-names></name>
<name><surname>Ndongo</surname><given-names>F.A.</given-names></name>
<name><surname>Chewa</surname><given-names>G.</given-names></name>
<name><surname>Rekacewicz</surname><given-names>C.</given-names></name>
<name><surname>Rousset</surname><given-names>D.</given-names></name>
<name><surname>Kfutwah</surname><given-names>A.</given-names></name>
<name><surname>Boisier</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Feasibility of early infant diagnosis of HIV in resource-limited settings: The ANRS 12140-PEDIACAM study in Cameroon</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e21840</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0021840</pub-id><pub-id pub-id-type="pmid">21818273</pub-id>
</element-citation></ref><ref id="B48-vaccines-12-01313"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>P.C.</given-names></name>
<name><surname>Mwango</surname><given-names>A.</given-names></name>
<name><surname>Moberley</surname><given-names>S.</given-names></name>
<name><surname>Brockman</surname><given-names>B.J.</given-names></name>
<name><surname>Connor</surname><given-names>A.L.</given-names></name>
<name><surname>Kalesha-Masumbu</surname><given-names>P.</given-names></name>
<name><surname>Mutembo</surname><given-names>S.</given-names></name>
<name><surname>Bweupe</surname><given-names>M.</given-names></name>
<name><surname>Chanda-Kapata</surname><given-names>P.</given-names></name>
<name><surname>Biemba</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0141455</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0141455</pub-id><pub-id pub-id-type="pmid">26513240</pub-id>
</element-citation></ref><ref id="B49-vaccines-12-01313"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bojang</surname><given-names>K.A.</given-names></name>
<name><surname>Akor</surname><given-names>F.</given-names></name>
<name><surname>Conteh</surname><given-names>L.</given-names></name>
<name><surname>Webb</surname><given-names>E.</given-names></name>
<name><surname>Bittaye</surname><given-names>O.</given-names></name>
<name><surname>Conway</surname><given-names>D.J.</given-names></name>
<name><surname>Jasseh</surname><given-names>M.</given-names></name>
<name><surname>Wiseman</surname><given-names>V.</given-names></name>
<name><surname>Milligan</surname><given-names>P.J.</given-names></name>
<name><surname>Greenwood</surname><given-names>B.</given-names></name>
</person-group><article-title>Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: A randomised controlled trial</article-title><source>PLoS Med.</source><year>2011</year><volume>8</volume><elocation-id>e1000409</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1000409</pub-id><pub-id pub-id-type="pmid">21304921</pub-id>
</element-citation></ref><ref id="B50-vaccines-12-01313"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dicko</surname><given-names>A.</given-names></name>
<name><surname>Konare</surname><given-names>M.</given-names></name>
<name><surname>Traore</surname><given-names>D.</given-names></name>
<name><surname>Testa</surname><given-names>J.</given-names></name>
<name><surname>Salamon</surname><given-names>R.</given-names></name>
<name><surname>Doumbo</surname><given-names>O.</given-names></name>
<name><surname>Rogier</surname><given-names>C.</given-names></name>
</person-group><article-title>The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: Results from a cluster randomized control</article-title><source>Malar. J.</source><year>2012</year><volume>11</volume><fpage>73</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-11-73</pub-id><pub-id pub-id-type="pmid">22423611</pub-id>
</element-citation></ref><ref id="B51-vaccines-12-01313"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dicko</surname><given-names>A.</given-names></name>
<name><surname>Toure</surname><given-names>S.O.</given-names></name>
<name><surname>Traore</surname><given-names>M.</given-names></name>
<name><surname>Sagara</surname><given-names>I.</given-names></name>
<name><surname>Toure</surname><given-names>O.B.</given-names></name>
<name><surname>Sissoko</surname><given-names>M.S.</given-names></name>
<name><surname>Diallo</surname><given-names>A.T.</given-names></name>
<name><surname>Rogier</surname><given-names>C.</given-names></name>
<name><surname>Salomon</surname><given-names>R.</given-names></name>
<name><surname>de Sousa</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine-pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial</article-title><source>BMC Public Health</source><year>2011</year><volume>11</volume><elocation-id>573</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2458-11-573</pub-id><pub-id pub-id-type="pmid">21767403</pub-id>
</element-citation></ref><ref id="B52-vaccines-12-01313"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patouillard</surname><given-names>E.</given-names></name>
<name><surname>Conteh</surname><given-names>L.</given-names></name>
<name><surname>Webster</surname><given-names>J.</given-names></name>
<name><surname>Kweku</surname><given-names>M.</given-names></name>
<name><surname>Chandramohan</surname><given-names>D.</given-names></name>
<name><surname>Greenwood</surname><given-names>B.</given-names></name>
</person-group><article-title>Coverage, adherence and costs of intermittent preventive treatment of malaria in children employing different delivery strategies in Jasikan, Ghana</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e24871</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0024871</pub-id><pub-id pub-id-type="pmid">22073137</pub-id>
</element-citation></ref><ref id="B53-vaccines-12-01313"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scates</surname><given-names>S.S.</given-names></name>
<name><surname>Finn</surname><given-names>T.P.</given-names></name>
<name><surname>Wisniewski</surname><given-names>J.</given-names></name>
<name><surname>Dadi</surname><given-names>D.</given-names></name>
<name><surname>Mandike</surname><given-names>R.</given-names></name>
<name><surname>Khamis</surname><given-names>M.</given-names></name>
<name><surname>Greer</surname><given-names>G.</given-names></name>
<name><surname>Serbantez</surname><given-names>N.</given-names></name>
<name><surname>Segbaya</surname><given-names>S.</given-names></name>
<name><surname>Owusu</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Costs of insecticide-treated bed net distribution systems in sub-Saharan Africa</article-title><source>Malar. J.</source><year>2020</year><volume>19</volume><fpage>105</fpage><pub-id pub-id-type="doi">10.1186/s12936-020-03164-1</pub-id><pub-id pub-id-type="pmid">32131834</pub-id>
</element-citation></ref><ref id="B54-vaccines-12-01313"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schellenberg</surname><given-names>J.R.</given-names></name>
<name><surname>Maokola</surname><given-names>W.</given-names></name>
<name><surname>Shirima</surname><given-names>K.</given-names></name>
<name><surname>Manzi</surname><given-names>F.</given-names></name>
<name><surname>Mrisho</surname><given-names>M.</given-names></name>
<name><surname>Mushi</surname><given-names>A.</given-names></name>
<name><surname>Alonso</surname><given-names>P.</given-names></name>
<name><surname>Mshinda</surname><given-names>H.</given-names></name>
<name><surname>Tanner</surname><given-names>M.</given-names></name>
<name><surname>Schellenberg</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: Evaluation of impact on survival</article-title><source>Malar. J.</source><year>2011</year><volume>10</volume><fpage>387</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-10-387</pub-id><pub-id pub-id-type="pmid">22208409</pub-id>
</element-citation></ref><ref id="B55-vaccines-12-01313"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Willey</surname><given-names>B.A.</given-names></name>
<name><surname>Armstrong Schellenberg</surname><given-names>J.R.</given-names></name>
<name><surname>Maokola</surname><given-names>W.</given-names></name>
<name><surname>Shirima</surname><given-names>K.</given-names></name>
<name><surname>Chemba</surname><given-names>M.</given-names></name>
<name><surname>Mshinda</surname><given-names>H.</given-names></name>
<name><surname>Alonso</surname><given-names>P.</given-names></name>
<name><surname>Tanner</surname><given-names>M.</given-names></name>
<name><surname>Schellenberg</surname><given-names>D.</given-names></name>
</person-group><article-title>Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania</article-title><source>Malar. J.</source><year>2011</year><volume>10</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-10-41</pub-id><pub-id pub-id-type="pmid">21320346</pub-id>
</element-citation></ref><ref id="B56-vaccines-12-01313"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Theiss-Nyland</surname><given-names>K.</given-names></name>
<name><surname>Ejersa</surname><given-names>W.</given-names></name>
<name><surname>Karema</surname><given-names>C.</given-names></name>
<name><surname>Kon&#x000e9;</surname><given-names>D.</given-names></name>
<name><surname>Koenker</surname><given-names>H.</given-names></name>
<name><surname>Cyaka</surname><given-names>Y.</given-names></name>
<name><surname>Lynch</surname><given-names>M.</given-names></name>
<name><surname>Webster</surname><given-names>J.</given-names></name>
<name><surname>Lines</surname><given-names>J.</given-names></name>
</person-group><article-title>Operational challenges to continuous LLIN distribution: A qualitative rapid assessment in four countries</article-title><source>Malar. J.</source><year>2016</year><volume>15</volume><fpage>131</fpage><pub-id pub-id-type="doi">10.1186/s12936-016-1184-y</pub-id><pub-id pub-id-type="pmid">26931237</pub-id>
</element-citation></ref><ref id="B57-vaccines-12-01313"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Theiss-Nyland</surname><given-names>K.</given-names></name>
<name><surname>Kon&#x000e9;</surname><given-names>D.</given-names></name>
<name><surname>Karema</surname><given-names>C.</given-names></name>
<name><surname>Ejersa</surname><given-names>W.</given-names></name>
<name><surname>Webster</surname><given-names>J.</given-names></name>
<name><surname>Lines</surname><given-names>J.</given-names></name>
</person-group><article-title>The relative roles of ANC and EPI in the continuous distribution of LLINs: A qualitative study in four countries</article-title><source>Health Policy Plan.</source><year>2017</year><volume>32</volume><fpage>467</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1093/heapol/czw158</pub-id><pub-id pub-id-type="pmid">28334799</pub-id>
</element-citation></ref><ref id="B58-vaccines-12-01313"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bakare</surname><given-names>M.O.</given-names></name>
<name><surname>Bello-Mojeed</surname><given-names>M.A.</given-names></name>
<name><surname>Munir</surname><given-names>K.M.</given-names></name>
<name><surname>Duduyemi</surname><given-names>O.O.</given-names></name>
<name><surname>Orovwigho</surname><given-names>A.O.</given-names></name>
<name><surname>Odetunde</surname><given-names>O.I.</given-names></name>
<name><surname>Taiwo</surname><given-names>O.G.</given-names></name>
<name><surname>Olofinlade</surname><given-names>J.A.</given-names></name>
<name><surname>Omotoso</surname><given-names>O.N.</given-names></name>
<name><surname>Famurewa</surname><given-names>O.H.</given-names></name>
<etal/>
</person-group><article-title>Improving access to interventions among mothers screened positive for post-partum depression (PPD) at National Programme on Immunization (NPI) clinics in south-western and south-eastern Nigeria&#x02014;A service development report</article-title><source>Matters</source><year>2017</year><volume>2017</volume><pub-id pub-id-type="doi">10.19185/matters.201707000005</pub-id></element-citation></ref><ref id="B59-vaccines-12-01313"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bakare</surname><given-names>M.O.</given-names></name>
<name><surname>Okoye</surname><given-names>J.O.</given-names></name>
<name><surname>Obindo</surname><given-names>J.T.</given-names></name>
</person-group><article-title>Introducing depression and developmental screenings into the national programme on immunization (NPI) in southeast Nigeria: An experimental cross-sectional assessment</article-title><source>Gen. Hosp. Psychiatry</source><year>2014</year><volume>36</volume><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2013.09.005</pub-id><pub-id pub-id-type="pmid">24140169</pub-id>
</element-citation></ref><ref id="B60-vaccines-12-01313"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Monterrosa</surname><given-names>E.C.</given-names></name>
<name><surname>Frongillo</surname><given-names>E.A.</given-names></name>
<name><surname>de Coss&#x000ed;o</surname><given-names>T.G.</given-names></name>
<name><surname>Bonvecchio</surname><given-names>A.</given-names></name>
<name><surname>Villanueva</surname><given-names>M.A.</given-names></name>
<name><surname>Thrasher</surname><given-names>J.F.</given-names></name>
<name><surname>Rivera</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Scripted messages delivered by nurses and radio changed beliefs, attitudes, intentions, and behaviors regarding infant and young child feeding in Mexico</article-title><source>J. Nutr.</source><year>2013</year><volume>143</volume><fpage>915</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.3945/jn.112.169235</pub-id><pub-id pub-id-type="pmid">23616510</pub-id>
</element-citation></ref><ref id="B61-vaccines-12-01313"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oladeji</surname><given-names>O.</given-names></name>
<name><surname>Campbell</surname><given-names>P.</given-names></name>
<name><surname>Jaiswal</surname><given-names>C.</given-names></name>
<name><surname>Chamla</surname><given-names>D.</given-names></name>
<name><surname>Oladeji</surname><given-names>B.</given-names></name>
<name><surname>Ajumara</surname><given-names>C.O.</given-names></name>
<name><surname>Minguiel</surname><given-names>L.M.</given-names></name>
<name><surname>Senesie</surname><given-names>J.</given-names></name>
</person-group><article-title>Integrating immunisation services into nutrition sites to improve immunisation status of internally displaced persons&#x02019; children living in Bentiu protection of civilian site, South Sudan</article-title><source>Pan Afr. Med. J.</source><year>2019</year><volume>32</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.11604/pamj.2019.32.28.15464</pub-id><pub-id pub-id-type="pmid">31143333</pub-id>
</element-citation></ref><ref id="B62-vaccines-12-01313"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Briere</surname><given-names>E.C.</given-names></name>
<name><surname>Ryman</surname><given-names>T.K.</given-names></name>
<name><surname>Cartwright</surname><given-names>E.</given-names></name>
<name><surname>Russo</surname><given-names>E.T.</given-names></name>
<name><surname>Wannemuehler</surname><given-names>K.A.</given-names></name>
<name><surname>Nygren</surname><given-names>B.L.</given-names></name>
<name><surname>Kola</surname><given-names>S.</given-names></name>
<name><surname>Sadumah</surname><given-names>I.</given-names></name>
<name><surname>Ochieng</surname><given-names>C.</given-names></name>
<name><surname>Watkins</surname><given-names>M.L.</given-names></name>
<etal/>
</person-group><article-title>Impact of integration of hygiene kit distribution with routine immunizations on infant vaccine coverage and water treatment and handwashing practices of Kenyan mothers</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>205</volume><issue>(Suppl. 1)</issue><fpage>S56</fpage><lpage>S64</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir779</pub-id><pub-id pub-id-type="pmid">22315387</pub-id>
</element-citation></ref><ref id="B63-vaccines-12-01313"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ryman</surname><given-names>T.K.</given-names></name>
<name><surname>Briere</surname><given-names>E.C.</given-names></name>
<name><surname>Cartwright</surname><given-names>E.</given-names></name>
<name><surname>Schlanger</surname><given-names>K.</given-names></name>
<name><surname>Wannemuehler</surname><given-names>K.A.</given-names></name>
<name><surname>Russo</surname><given-names>E.T.</given-names></name>
<name><surname>Kola</surname><given-names>S.</given-names></name>
<name><surname>Sadumah</surname><given-names>I.</given-names></name>
<name><surname>Nygren</surname><given-names>B.L.</given-names></name>
<name><surname>Ochieng</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Integration of routine vaccination and hygiene interventions: A comparison of 2 strategies in Kenya</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>205</volume><issue>(Suppl. 1)</issue><fpage>S65</fpage><lpage>S76</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir777</pub-id><pub-id pub-id-type="pmid">22315389</pub-id>
</element-citation></ref><ref id="B64-vaccines-12-01313"><label>64.</label><element-citation publication-type="book"><source>Collaborative Action Strategy (CAS) for Health Campaign Effectiveness, 2024&#x02013;2028</source><publisher-name>Health Campaign Effectiveness Coalition</publisher-name><publisher-loc>Decatur, GA, USA</publisher-loc><year>2023</year></element-citation></ref><ref id="B65-vaccines-12-01313"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chamla</surname><given-names>D.</given-names></name>
<name><surname>Luo</surname><given-names>C.</given-names></name>
<name><surname>Adjorlolo-Johnson</surname><given-names>G.</given-names></name>
<name><surname>Vandelaer</surname><given-names>J.</given-names></name>
<name><surname>Young</surname><given-names>M.</given-names></name>
<name><surname>Costales</surname><given-names>M.O.</given-names></name>
<name><surname>McClure</surname><given-names>C.</given-names></name>
</person-group><article-title>Integration of HIV infant testing into immunization programmes: A systematic review</article-title><source>Paediatr. Int. Child Health</source><year>2015</year><volume>35</volume><fpage>298</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1080/20469047.2015.1109233</pub-id><pub-id pub-id-type="pmid">26744153</pub-id>
</element-citation></ref><ref id="B66-vaccines-12-01313"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cleland</surname><given-names>J.</given-names></name>
<name><surname>Shah</surname><given-names>I.H.</given-names></name>
<name><surname>Daniele</surname><given-names>M.</given-names></name>
</person-group><article-title>Interventions to Improve Postpartum Family Planning in Low- and Middle-Income Countries: Program Implications and Research Priorities</article-title><source>Stud. Fam. Plan.</source><year>2015</year><volume>46</volume><fpage>423</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1111/j.1728-4465.2015.00041.x</pub-id></element-citation></ref><ref id="B67-vaccines-12-01313"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ahmed</surname><given-names>S.T.</given-names></name>
<name><surname>Haider</surname><given-names>S.S.</given-names></name>
<name><surname>Hanif</surname><given-names>S.</given-names></name>
<name><surname>Anwar</surname><given-names>H.B.</given-names></name>
<name><surname>Mehjabeen</surname><given-names>S.</given-names></name>
<name><surname>Closser</surname><given-names>S.</given-names></name>
<name><surname>Bazant</surname><given-names>E.</given-names></name>
<name><surname>Sarker</surname><given-names>M.</given-names></name>
</person-group><article-title>A scoping review on integrated health campaigns for immunization in low- and middle-income countries</article-title><source>Health Policy Plan.</source><year>2023</year><volume>38</volume><fpage>1198</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1093/heapol/czad082</pub-id><pub-id pub-id-type="pmid">37699072</pub-id>
</element-citation></ref><ref id="B68-vaccines-12-01313"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>C.</given-names></name>
<name><surname>Giattas</surname><given-names>M.R.</given-names></name>
<name><surname>Holroyd</surname><given-names>T.</given-names></name>
<name><surname>Pfitzer</surname><given-names>A.</given-names></name>
<name><surname>Engel</surname><given-names>D.</given-names></name>
<name><surname>Sidibe</surname><given-names>A.</given-names></name>
<name><surname>Holloway</surname><given-names>M.</given-names></name>
<name><surname>Bloem</surname><given-names>P.</given-names></name>
<name><surname>Fields</surname><given-names>R.</given-names></name>
<name><surname>Shimp</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidence</article-title><source>Vaccine</source><year>2022</year><volume>40</volume><issue>(Suppl. 1)</issue><fpage>A94</fpage><lpage>A99</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2021.12.066</pub-id><pub-id pub-id-type="pmid">35105493</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vaccines-12-01313-f001"><label>Figure 1</label><caption><p>Study flow diagram (PRISMA Diagram), systematic review update 2011&#x02013;2020.</p></caption><graphic xlink:href="vaccines-12-01313-g001" position="float"/></fig><table-wrap position="float" id="vaccines-12-01313-t005"><object-id pub-id-type="pii">vaccines-12-01313-t005_Table 5</object-id><label>Table 5</label><caption><p>A qualitative summary of the effect of integrated service delivery on immunization and linked service outcomes (<italic toggle="yes">n</italic> = 25 *) by immunization delivery platform, linked health service, and a combination of integration strategies, systematic review update 2011&#x02013;2020.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="12" align="center" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Qualitative Summary <sup>1</sup> of the Effect of Integrated Service Delivery</th></tr><tr><th align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="6" align="center" valign="top" style="border-bottom:solid thin" rowspan="1">Immunization Outcome <sup>2,3</sup></th><th colspan="6" align="center" valign="top" style="border-bottom:solid thin" rowspan="1">Linked MCH Service Outcome <sup>2,3</sup></th></tr><tr><th align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Study</th><th align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">EPI Platform</th><th align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Linked Health Service(s)</th><th align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">NOT MEASURED</th><th align="center" valign="top" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">NEG</th><th align="center" valign="top" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">M-NEG</th><th align="center" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">STATIC</th><th align="center" valign="top" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">M-POS</th><th align="center" valign="top" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">POS</th><th align="center" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">NOT MEASURED</th><th align="center" valign="top" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">NEG</th><th align="center" valign="top" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">M-NEG</th><th align="center" valign="top" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">STATIC</th><th align="center" valign="top" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">M-POS</th><th align="center" valign="top" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">POS</th></tr></thead><tbody><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Goodson 2012 &#x00026; Kulkarni 2010 [<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Madagascar</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Campaign&#x02014;mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>A C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>A C</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Birukila 2017 [<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Campaign&#x02014;mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">PHC</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>C</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Habib 2017 [<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pakistan</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Campaign&#x02014;mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nutrition, PHC</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>B C</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Balasubramaniam 2018 [<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;outreach</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>B</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
<bold>B</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Cooper 2015 [<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Liberia</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>B C</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Dulli 2016 [<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Rwanda</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>B C</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Vance 2014 [<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Ghana, Zambia</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Cooper 2020 [<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malawi</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine- mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
<bold>A C E</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>A C E</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nelson 2019 [<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Liberia</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>B C E</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>B C E</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Yugbare Belemsaga 2018 [<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Burkina Faso</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>A B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>A B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Odafe 2020 [<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
<bold>C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Ong&#x02019;ech 2012 [<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Kenya</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>C</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">McCollum 2012 [<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malawi</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>B C</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Goodson 2013 &#x00026;Wallace 2014 [<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Tanzania</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
<bold>A B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>A B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang 2015 [<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Zambia </td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>A B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>A B C</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Bojang 2011 [<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Gambia</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;outreach</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
<bold>A</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
<bold>A</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Dicko 2011 [<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Mali</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>A</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>A</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Schellenberg 2011 &#x00026; Willey 2011 [<xref rid="B54-vaccines-12-01313" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01313" ref-type="bibr">55</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Tanzania</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>A</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>A</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Patouillard 2011 [<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Ghana</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;outreach</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>A B</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
<bold>A B</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Monterrosa 2013 [<xref rid="B60-vaccines-12-01313" ref-type="bibr">60</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Mexico</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nutrition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>B</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>B</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Oladeji 2019 [<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">South Sudan</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mixed</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nutrition</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>C E</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>C E</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Briere 2012&#x00026; Ryman 2012 [<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Kenya</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">WASH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>A B C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>A B C</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Bawa 2019 [<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mobile</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria, PHC, Nutrition, WASH</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>C</bold>
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Edmond 2020 [<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Afghanistan</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;mobile</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Nutrition, PHC</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
<bold>C</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Hodges 2015 [<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>]</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Sierra Leone</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine&#x02014;facility</td><td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">FP, Nutrition</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
<bold>C E</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#ADB9CA" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D6DCE5" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#E2F0D9" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#C5E0B4" rowspan="1" colspan="1">
<bold>C E</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p>Notes: EPI = expanded program of immunizations; HIV = human immunodeficiency virus; FP = family planning; MCH = maternal and child health; PHC = primary healthcare; WASH = water, sanitation, and hygiene. * studies that reported at least one immunization and/or linked health service outcome. <sup>1</sup> primary outcomes that were considered in this qualitative summary are designated in bold in <xref rid="vaccines-12-01313-t001" ref-type="table">Table 1</xref>. <sup>2</sup> a single qualitative summary was used to describe the direction of effect of integration for the primary outcome(s) for immunization and for the linked health service separately. The terms used were defined as follows: &#x0201c;not measured&#x0201d;&#x02014;no outcome measured or no non-integration comparison group available; &#x0201c;negative&#x0201d;&#x02014;lower coverage or service provision in the integration compared to the non-integration group; &#x0201c;mixed negative&#x0201d;&#x02014;some outcomes were lower in the integration compared to the non-integration group but others remained static; &#x0201c;static&#x0201d;&#x02014;no meaningful difference in coverage or service provision between integration and non-integration groups; &#x0201c;mixed positive&#x0201d;&#x02014;some outcomes were higher in the integration compared to the non-integration group, but others remained static; or &#x0201c;positive&#x0201d;&#x02014;higher coverage or services in the integration compared to the non-integration group. <sup>3</sup> integration strategies were categorized in one or more of the following ways: A. extra services provided by immunization staff (i.e., testing, treatment, referrals, etc.); B. extra information and/or counseling provided by immunization staff (i.e., one-on-one consultation, the provision of informational materials, etc.); C. the co-location of services (e.g., same timing or same physical location of immunization delivery and linked health service); D. vaccination provided by non-immunization staff; E. extra information and/or counseling provided by non-immunization staff (i.e., screening, health education, or immunization promotion, etc.).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vaccines-12-01313-t006"><object-id pub-id-type="pii">vaccines-12-01313-t006_Table 6</object-id><label>Table 6</label><caption><p>Implementation considerations reported for integrated service delivery of maternal and child health services with immunization programs, systematic review update 2011&#x02013;2020.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Category</th><th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Processes, Enablers, and Barriers Affecting Service Integration</th><th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References </th></tr></thead><tbody><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Policy and governance topics</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Consistency of leadership support</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>,<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Governments and donors seeking efficiency amidst multiple priorities</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reducing financial access barriers to the integration of other primary healthcare services with immunization</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>]</td></tr><tr><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Design of integrated service delivery</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Optimize co-location of additional staff, especially if extra tasks require more time (e.g., counseling) or skills</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ensure good matches in terms of of cadence, target groups, and types of services (e.g., preventive rather than curative services may more amenable to integration with immunization)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ensure additional service requirements do not compromise uptake or quality</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Use integration as an opportunity to provide services to areas/populations that are difficult to reach</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>]</td></tr><tr><td rowspan="6" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Human resources for health</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Managing workload and time demands for extra tasks</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>,<xref rid="B29-vaccines-12-01313" ref-type="bibr">29</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01313" ref-type="bibr">53</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>,<xref rid="B60-vaccines-12-01313" ref-type="bibr">60</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Additional and skilled staff may be needed (e.g., counseling)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>,<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Motivation and empowerment of healthcare staff to provide expanded care, which healthcare workers generally perceive as better in quality and responsiveness</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Training that is (a) harmonized for vaccinators and for providers of linked health service; (b) includes client communications/mobilization; and (c) includes integration processes and tools</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-12-01313" ref-type="bibr">24</xref>,<xref rid="B27-vaccines-12-01313" ref-type="bibr">27</xref>,<xref rid="B29-vaccines-12-01313" ref-type="bibr">29</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B54-vaccines-12-01313" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01313" ref-type="bibr">55</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Involving community-based health workers to support integrated service delivery</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B24-vaccines-12-01313" ref-type="bibr">24</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ensuring that staff are willing to collaborate in providing additional services</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>]</td></tr><tr><td rowspan="5" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Management, logistics, and costs</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coordinated program planning across program managers and between staff</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Consistency of supplies (particularly for linked service) and coordinated logistics</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B30-vaccines-12-01313" ref-type="bibr">30</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B48-vaccines-12-01313" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Efficiency may lower costs of integrated service</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-vaccines-12-01313" ref-type="bibr">27</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B52-vaccines-12-01313" ref-type="bibr">52</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Integrating professional staff may increase costs</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ensuring infrastructure is supportive (e.g., privacy)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-vaccines-12-01313" ref-type="bibr">29</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>]</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Operational tools, reporting and recording</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Consolidation of information systems and reporting, including home-based records</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-vaccines-12-01313" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-12-01313" ref-type="bibr">21</xref>,<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ensuring time for documentation of extra services</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B56-vaccines-12-01313" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Job aids and other tools to support implementation of linked service and referral between programs</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-vaccines-12-01313" ref-type="bibr">29</xref>,<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01313" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B45-vaccines-12-01313" ref-type="bibr">45</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>]</td></tr><tr><td rowspan="6" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Community and client topics</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promote care seeking, with perceptions of integrated services as more responsive and client-focused</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B24-vaccines-12-01313" ref-type="bibr">24</xref>,<xref rid="B27-vaccines-12-01313" ref-type="bibr">27</xref>,<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>,<xref rid="B31-vaccines-12-01313" ref-type="bibr">31</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B49-vaccines-12-01313" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01313" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01313" ref-type="bibr">51</xref>,<xref rid="B57-vaccines-12-01313" ref-type="bibr">57</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ensuring stigma/sensitivity does not hamper uptake</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-vaccines-12-01313" ref-type="bibr">23</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B58-vaccines-12-01313" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01313" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ensuring family time and travel costs do not increase</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Account for need to involve spouse in care decisions</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ensuring integrated services address common barriers to uptake</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-vaccines-12-01313" ref-type="bibr">22</xref>,<xref rid="B27-vaccines-12-01313" ref-type="bibr">27</xref>,<xref rid="B28-vaccines-12-01313" ref-type="bibr">28</xref>,<xref rid="B32-vaccines-12-01313" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01313" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-12-01313" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01313" ref-type="bibr">36</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01313" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01313" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01313" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01313" ref-type="bibr">44</xref>,<xref rid="B46-vaccines-12-01313" ref-type="bibr">46</xref>,<xref rid="B61-vaccines-12-01313" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01313" ref-type="bibr">62</xref>,<xref rid="B63-vaccines-12-01313" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ensuring multiple channels of communication on integrated health services</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-vaccines-12-01313" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01313" ref-type="bibr">26</xref>,<xref rid="B33-vaccines-12-01313" ref-type="bibr">33</xref>,<xref rid="B38-vaccines-12-01313" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01313" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01313" ref-type="bibr">40</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Note: this table outlines the implementation considerations extracted from studies, reporting contributors to the degree to which service integration affected outcomes for the linked service or immunization.</p></fn></table-wrap-foot></table-wrap></floats-group></article>